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LIPID BILAYER-INTEGRATED SPPl 
CONNECTOR PROTEIN NANOPORE AND 
SPPl CONNECTOR PROTEIN VARIANTS 
FOR USE AS LIPID BILAYER-INTEGRATED 
NANOPORE 
RELATED APPLICATIONS 
This application is a § 371 National State Application of 
PCT/CN2016/013702 filed Jan. 15, 2016, which claims 
priority from U.S. Provisional Application Ser. No. 62/104, 
375 filed Jan. 16, 2015, the entire disclosure of which are 
incorporated herein by this reference. 
GOVERNMENT INTEREST 
This invention was made with govermnent support under 
EB012135 and EB003730 awarded by the National Insti-
tutes of Health. The government has certain rights in the 
invention. 
SEQUENCE LISTING 
The instant application contains a Sequence Listing which 
has been filed electronically in ASCII format and is hereby 
incorporated by reference in its entirety. Said ASCII copy, 
created on Jul. 13, 2017, is named 2935720-3_SL.txt and is 
34,432 bytes in size. 
TECHNICAL FIELD 
The presently-disclosed subject matter relates to an engi-
neered SPPl viral DNA-packaging motor connector protein 
that can be incorporated into a lipid membrane to form an 
electroconductive aperture. 
BACKGROUND 
Highly sensitive detection and characterization of minute 
quantities of chemicals and biochemicals represent desirable 
goals of modern analytical technologies. Robust molecular 
sensing devices would find uses in a wide range of biomedi-
cal, industrial, environmental, forensic, security and other 
contexts, for example, in the detection and identification of 
pathogens and chemicals at extremely low concentrations 
for disease diagnosis and environmental monitoring, in high 
throughput DNA sequencing and other genomics applica-
tions, and elsewhere. 
Analytical methodologies have been described that 
employ intermolecular affinity binding interactions, typi-
cally non-covalent in nature, to detect binding or "capture" 
of an analyte of interest by a specific affinity ligand, for 
instance, including detection of bacterial, viral, parasitic or 
other microbial pathogens or pathogen-associated antigens, 
and detection of antibodies, cancer markers, and other 
analytes (e.g., Kittigul et al., Am J Trap Med Hyg. 1998 
September; 59(3):352-6; Cordiano et al., J Immunol Meth-
ods. 1995 Jan. 13; 178(1):121-30; Olson et al., J Immunol 
Methods. 1990 Nov. 6; 134(1):71-9; Nerurkar et al., J Clin 
Microbial. 1984 July; 20(1):109-14; Jia et al., J Viral 
Methods. 2009 October; 161(1):38-43; He et al., Clin Vac-
cine Immunol. 2007 May; 14(5):617-23; Xu et al., J Clin 
Microbial. 2006 August; 44(8):2872-8; Che et al., J Clin 
Microbial. 2004 June; 42(6):2629-35; Hunt et al., Brown et 
al., Am J Trap Med Hyg. 2001 September; 65(3):208-13; 
Loa et al., Avian Dis. 2000 July-September; 44(3):498-506; 
Lubenko et al., Transfus Med. 2000 September; 10(3):213-
2 
8; Chanteau et al., Int J Tuberc Lung Dis. 2000 April; 
4(4):377-83; Brinker et al., J Clin Microbial. 1998 April; 
36(4):1064-9; Vyse et al., J Viral Methods. 1997 January; 
63(1-2):93-101; Peterson et al., J Clin Microbial. 1997 
5 January; 35(1):208-12; Lairmore et al., AIDS Res Hum 
Retroviruses. 1993 June; 9(6):565-71; Heller et al., Vet 
Microbial. 1993 October; 37(1-2):127-33; van Loon et al., 
Epidemiol Infect. 1992 February; 108(1 ): 165-74; Wolf-Rog-
ers et al., J Immunol Methods. 1990 Oct. 19; 133(2):191-8; 
10 Barsoum et al., Exp Parasitol. 1990 July; 71(1):107-13; 
Hierholzer et al., J Clin Microbial. 1989 June; 27(6): 1243-9; 
Hurley et al., J Immunoassay. 1986; 7(4):309-36; Wolff et 
al., Cancer Res. 53:2560-65 (1993); see generally, e.g., 
Harlow and Lane, Antibodies: A Laboratory Manual, Cold 
15 Spring Harbor Laboratory, 1988; Weir, D. M., Handbook of 
Experimental Immunology, 1986, Blackwell Scientific, Bos-
ton, Mass.). 
Beyond detection of the presence of an analyte following 
its involvement in an affinity binding interaction, sophisti-
20 cated technologies are emerging that permit characterization 
of the analyte, often by comparing a single- or multiparam-
eter physicochemical profile of the analyte to type-charac-
teristic profiles generated using one or more known refer-
ence standards, and hence referred to as "fingerprinting" 
25 techniques ( e.g., Li et al., Rapid Commun Mass Spectrom. 
2009 23(22):3533-3542; Ali et al., J Agric Food Chem. 
2009; Leski et al., Appl Environ Microbial. Sep. 18, 2009; 
Weinkopff et al., J Parasitol. Jun. 18, 2009; Song et al., 
Proteomics. 2009 9(11):3090-9; Ortea et al., J Agric Food 
30 Chem. 2009 57(13):5665-72; Amini, Pharmeur Sci Notes. 
2009(1): 11-6; Shi et al., Biol Phann Bull. 2009 32(1):142-6; 
Sun et al., J Chromatogr A. 2009 1216(5):830-6; Yin et al., 
Phytopathology. 2003 93(8):1006-13; Roy et al., Clin Can-
cer Res. 2008 14(20):6610-7; Pei et al., Zhongguo Zhong 
35 Yao Za Zhi. 2008 33(14):1662-8;Arthur, Methods Mo! Med. 
2008, 141:257-70; Zhao et al., Se Pu 2008 26(1):43-9; Woo 
et al., Anal Chem. 2008 80(7):2419-25; Damodaran et al., 
Genomics Proteomics Bioinformatics. 2007 5(3-4):152-7; 
Fellstrom et al., J Microbial Methods. 2008 72(2): 133-40; 
40 Song et al., Conf Proc IEEE Eng Med Biol Soc. 2006 
1 :4556-9; De Vuyst et al., Int J Food Microbial. 2008 
125(1):79-90). 
The use of transmembrane channels has been demon-
strated in stochastic analyte detection (Bayley et al., 2001 
45 Nature 13:225-230), an electrochemical approach relying on 
the real-time observation of individual binding events 
between single substrate molecules and a receptor, as evi-
denced by altered ( e.g., decreased or increased in a statis-
tically significant manner) electrical conductance by the 
50 channel (receptor) as a result of substrate ( analyte) binding. 
A wide range of processes, such as the transport of DNA, 
RNA, pharmaceutical agents, peptides, proteins, and poly-
mers, have been studied by such approaches, for example, 
using electrophysiological measurements of individual 
55 membrane channels (Thieffry et al., 1988 EMBO J 7:1449; 
Hinnah et al., 2002 Biophys J 83:899; Alcayaga et al., 1992 
FEBS Lett. 311:246-50; Benz et al., 1986 J Bacterial 165: 
978; Movileanu et al., 2000 Nat. Biotechnol. 18:1091). 
For instance, the transient blockade of ionic current 
60 through the Staphylococcus aureus alpha-hemolysin (a-HL) 
channel, a bacterial transmembrane pore-forming protein, 
has been used to measure the length of single-stranded DNA 
or RNA (Kasianowicz et al. Proc. Natl. Acad. Sci. USA 93, 
13770-13773 (1996)). Subsequently, DNA hairpin mol-
65 ecules have been used to decelerate the DNA translocation 
rate through the alpha-hemolysin (a-HL) pore, to demon-
strate the ability of a transmembrane ion channel to dis-
US 10,648,966 B2 
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criminate between single nucleotide polymorphisms (Ver-
coutere et al., 2001 Nat. Biotechnol. 19:248). Detection of 
base pair stacking and strand orientation within the pore 
have also been investigated (Vercoutere et al., 2003 Nucl Ac. 
Res. 31:1311; Howorka et al., 2001 Nat. Biotechnol. 19:636; 5 
deGuzman et al., 2006 Nucl. Ac. Res. 34:6425). The channel 
of a-HL with a covalently attached adapter molecule has 
been shown to discriminate the nucleotides A, T, G, and C 
(Clarke et al., 2009 Nat. Nanotechnol. 4:265). 
The a-HL channel has also been reported to provide some 10 
ability to translocate small peptides (See e.g., Mohammad, 
et al., "Protein Sensing with engineered protein nanopores," 
Methods Mo! Biol. 2012, 870:21-37; Jetha, et al., "Nano-
pore Analysis of Wild-Type and Mutant Prion Protein 
(PrPc): Single Molecule Discrimination and PrPc Kinetics," 15 
PLOS ONE, 2013, 8(2); Mereuta, et al., "Slowing down 
single-molecule trafficking through a protein nanopore 
reveals intermediates for peptide translocation," Scientific 
Reports, 2014, 4:3885; Rosen, et al., "Single-molecule site-
specific detection of protein phosphorylation with a nano- 20 
pore," Nat Biotechnol, 2014 February, 32(2): 179-81); Mov-
ileanu, "Watching single proteins using engineered 
nanopores," Protein Pept Lett. 2014 March, 21(3):235-46). 
However, at only about 1.2-1.5 nm, only a limited number 
of peptides are capable of being translocated through the 25 
a-HL channel and there is not an ability to differentiate 
between different peptides. 
Other protein channels that have been investigated 
include alamethicin for detection of polyethylene glycol 
(Bezrukov, 2000 J Membr Biol. 174:1-13), and the reengi- 30 
neered MspA protein from M. smegmatis for translocation of 
ssDNA (Butler et al., 2008 Proc. Nat. Acad. Sci. USA 
105:20647). Most studies involving nucleic acid transport 
through nanopores have focused on a-HL. However, the 
limiting lumen diameter of a-HL (about 1.2-1.5 nm) and 35 
other channels has restricted their DNA and RNA applica-
tions to translocation of single-stranded nucleic acid (Song, 
1996 Science 274:1859). A similar limitation was also 
reported for the MspA nanopore (Butler et al., 2008). 
In a small number of other membrane pore systems, 40 
evidence of double-stranded DNA ( dsDNA) transport across 
the membrane has been presented (Szabo et al., 2002 Cell 
Physiol Biochem 12: 127; Mobasheri et al. 2002 Eur J 
Bipohys 31:389; Carneiro et al., 2003 Biochim Biophys 
Acta 1612:144), but these systems are not robust and rep- 45 
resent poor candidates for widespread use such as biomedi-
cal applications, due to their undesirable voltage gating 
properties and the associated signal fluctuation. For this 
reason, their potential is considered limited and researchers 
have switched instead to fabricating synthetic metal or 50 
silicon nanopores for potential use in DNA sequencing 
(Smeets et al, 2006 Nano Lett 6:89; Wang et al., 2001 Nat. 
Biotechnol. 19:622; Iqbal et al., 2007 Nat. Nano 2:243). 
Such synthetic nanopores, however, suffer from shortcom-
ings due to difficulties in reliably producing replicated 55 
structures having consistent properties from batch to batch, 
and also lack versatility with regard to the ability to engineer 
modifications to pore structures and/or to serve as substrates 
for modification by a wide range of chemical conjugation. 
As a result, the search for superior alternatives to currently 60 
available protein nanopores is still ongoing. 
There is a need for improved compositions and methods 
that would provide a versatile membrane conductive channel 
platform for sensitively detecting and characterizing a wide 
range of analytes, having a lumen capable of accommodat- 65 
ing dsDNA and polypeptides, that can be reliably and 
reproducibly assembled, that is not susceptible to voltage 
4 
gating under working conditions, and that can be readily 
modified to feature a wide variety of specific affinity recep-
tors for use in the detection and characterization of different 
analytes. The presently disclosed invention embodiments 
fulfill such a need, and offer other related advantages. 
SUMMARY 
The presently-disclosed subject matter meets some or all 
of the above-identified needs, as will become evident to 
those of ordinary skill in the art after a study of information 
provided in this document. 
This S=ary describes several embodiments of the 
presently-disclosed subject matter, and in many cases lists 
variations and permutations of these embodiments. This 
Summary is merely exemplary of the numerous and varied 
embodiments. Mention of one or more representative fea-
tures of a given embodiment is likewise exemplary. Such an 
embodiment can typically exist with or without the feature 
(s) mentioned; likewise, those features can be applied to 
other embodiments of the presently-disclosed subject mat-
ter, whether listed in this S=ary or not. To avoid exces-
sive repetition, this Summary does not list or suggest all 
possible combinations of such features. 
The presently disclosed subject matter includes a nucleic 
acid molecule encoding an SPPl connector polypeptide 
variant. In some embodiments, the SPPl connector poly-
peptide variant comprises an amino acid sequence having at 
least 95% sequence identity to the sequence shown in SEQ 
ID NO:4, SEQ ID NO:6, SEQ ID NO:8, or SEQ ID NO:10. 
In some embodiments, the SPPl connector polypeptide 
variant comprises an amino acid sequence having at least 
95% sequence identity to the sequence of SEQ ID NO:4, 
SEQ ID NO:6, SEQ ID NO:8, or SEQ ID NO:10. In some 
embodiments, the SPPl connector polypeptide variant com-
prises an amino acid sequence having at least 99% sequence 
identity to the sequence of in SEQ ID NO:4, SEQ ID NO:6, 
SEQ ID NO: 8, or SEQ ID NO: 10. In some embodiments, the 
SPPl connector polypeptide variant comprises the amino 
acid sequence of SEQ ID NO:4, SEQ ID NO:6, SEQ ID 
NO:8, or SEQ ID NO: 10. In some embodiments, the nucleic 
acid molecule encoding an SPPl connector polypeptide 
variant includes the sequence of SEQ ID NO:3, SEQ ID 
NO:5, SEQ ID NO:7, or SEQ ID NO:9. 
The presently disclosed subject matter further includes a 
SPPl connector polypeptide variant, wherein the polypep-
tide comprises an amino acid sequence having at least 95% 
sequence identity to the sequence of SEQ ID NO:4, SEQ ID 
NO:6, SEQ ID NO:8, or SEQ ID NO:10. at least 95% 
sequence identity to the sequence shown in SEQ ID NO:4, 
SEQ ID NO:6, SEQ ID NO:8, or SEQ ID NO:10. In some 
embodiments, the SPPl connector polypeptide variant com-
prises an amino acid sequence having at least 95% sequence 
identity to the sequence of SEQ ID NO:4, SEQ ID NO:6, 
SEQ ID NO: 8, or SEQ ID NO: 10. In some embodiments, the 
SPPl connector polypeptide variant comprises an amino 
acid sequence having at least 99% sequence identity to the 
sequence of in SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, 
or SEQ ID NO:10. In some embodiments, the SPPl con-
nector polypeptide variant comprises the amino acid 
sequence of SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, 
or SEQ ID NO: 10. 
The presently disclosed subject matter further includes a 
SPPl connector polypeptide variant, wherein the polypep-
tide comprises an amino acid sequence encoded by a nucleic 
acid molecule having the sequence of SEQ ID NO:3, SEQ 
ID NO:5, SEQ ID NO:7, or SEQ ID NO:9. 
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The presently disclosed subject matter further includes a 
conductive channel-containing membrane, which includes 
(a) a membrane layer, and (b) a SPPl connector polypeptide 
variant that is incorporated into the membrane layer to form 
an aperture through which conductance can occur when an 5 
electrical potential is applied across the membrane. 
tion that sets forth illustrative embodiments, in which the 
principles of the invention are used, and the accompanying 
drawings of which: 
FIG. 1: Structure of the channel ofSPPl DNA packaging 
motor. (a) Side view and (b) top view from PDB file 2JES 
showing hydrophilic (red), hydrophobic (blue) and neutral 
(white) amino acids; and dimensions of the channel (PDB: 
2JES). (c) Coomasie-blue stained SDS PAGE showing the 
purified SPPl channel subunits gp6. 
In some embodiments the SPPl connector polypeptide 
variant of the conductive channel-containing membrane is 
selected from (i) a polypeptide comprising an amino acid 
sequence having at least 95% sequence identity to the 10 
sequence of SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, 
FIG. 2: Electrophysiological properties of Membrane-
embedded SPPl connector. (a) Current trace showing the 
insertion of SPPl connector into the planar membrane with 
a characteristic step size of -200 pA at 50 m V. (b) Conduc-
tance distribution based on 104 insertion events. ( c) Current-
Voltage trace acquired from -50----;.50 mV. Buffer: 1 M KC!, 
5 mM HEPES, pH 8. 
or SEQ ID NO: 1 O; (ii) a polypeptide comprising an amino 
acid sequence having at least 99% sequence identity to the 
sequence of SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, 
15 
or SEQ ID NO: 1 O; (iii) a polypeptide comprising the amino 
acid sequence of SEQ ID NO:4, SEQ ID NO:6, SEQ ID 
NO:8, or SEQ ID NO:10; and (iv) a polypeptide comprising 
FIG. 3: Peptide translocation through SPPl connector. (a) 
Current trace showing a burst of current blockage events 
with characteristic current amplitude and dwell time (insert) 
indicating the translocation of TAT peptides. (b) Rate of 
peptide translocation as a function of peptide concentration 
an amino acid sequence encoded by a nucleic acid molecule 
having the sequence of SEQ ID NO:3, SEQ ID NO:5, SEQ 20 
ID NO:7, or SEQ ID NO:9. 
In some embodiments of the conductive channel-contain-
ing membrane the SPPl connector polypeptide variant com-
prises a detectable label. In some embodiments of the 
conductive channel-containing membrane, the detectable 
label is selected from the group consisting of a colorimetric 
indicator, a (iCMS tag compound, a fluorescent indicator, a 
luminescent indicator, a phosphorescent indicator, a radio-
metric indicator, a dye, an enzyme, a substrate of an enzyme, 
an energy transfer molecule, a quantum dot, a metal particle 
and an affinity label. 
In some embodiments of the conductive channel-contain-
ing membrane, the membrane layer comprises a lipid layer. 
In some embodiments, the lipid layer comprises amphip-
athic lipids. In some embodiments, the amphipathic lipids 
comprise phospholipids and the lipid layer comprises a lipid 
bilayer. In some embodiments, the lipid layer is selected 
from the group consisting of a planar membrane layer and a 
liposome. In some embodiments, the liposome is selected 
from the group consisting of a multilamellar Ii po some and a 
unilamellar liposome. In some embodiments, the incorpo-
rated SPPl connector polypeptide variant is mobile in the 
membrane layer. 
In some embodiments, the conductive channel-containing 
membrane is capable of translocating a single stranded 
nucleic acid molecule, a double-stranded nucelic acid mol-
ecule, and/or a polypeptide through the aperture when the 
electrical potential is applied, wherein said conductive chan-
nel-containing membrane is capable of polypeptide detec-
tion, identification, sequencing, and discrimination. 
The presently-disclosed subject matter further includes a 
method of sensing a molecule using a conductive channel-
containing membrane as disclosed herein. In some embodi-
ments, the molecule is a polypeptide. In some embodiments, 
the molecule is a nucleic acid molecule. In some embodi-
ments, the nucleic acid molecule is a double-stranded 
nucleic acid molecule. 
The presently-disclosed subject matter further includes a 
method of DNA sequencing using a conductive channel-
containing membrane as disclosed herein. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The novel features of the invention are set forth with 
particularity in the appended claims. A better understanding 
of the features and advantages of the present invention will 
be obtained by reference to the following detailed descrip-
(n=3). (c) Histogram of current blockage percentage from 
285 events. (d) Dwell time of peptide translocation events 
fitted with a single exponential function. Applied voltage: 50 
25 m V; Buffer: 1 M KC!, 5 mM HEPES, pH 8. 
FIG. 4: Determining the conformation states of TAT 
peptide. Current trace (left), current blockage distribution 
(middle) and conformation (right) for (a) Oxidized dimer 
state of TAT peptide; (b) reduced monomer state of TAT 
30 peptide; and ( c) Cy3-conjugated TAT monomer. Applied 
voltage: 50 m V; Buffer: 1 M KC!, 5 mM HEPES, pH 8. Total 
number of events: 858 in A; 367 in Band 1128 in C. 
FIG. 5: Single molecule fluorescent images validating 
TAT peptide translocation. (a) The upper row is the image 
35 showing the detection of Cy3-labeled TAT peptide from the 
fractions collected from patch clamp at 0, 20, 40 and 60 
mins. The lower row shows the background resulting from 
the self-permeation of the TAT peptide which is the HIV 
membrane penetrating peptide. Excitation □: 532 nm; laser 
40 power: 5 mW; 60x objective (N.A.=1.4, oil immersion); 
Exposure time: 500 ms. (b) Quantitative analysis showing 
the increase in Cy3-TAT peptide signal in presence of SPPl 
connector compared to control without connector. The error 
bar is based on counting of the spots from different image 
45 areas. Applied voltage: 50 mV; Buffer: 1 M KC!, 5 mM 
HEPES, pH 8. 
FIG. 6: Real-time assessment of the conformation states 
of TAT peptide. (a) Continuous current trace showing tran-
sition of oxidized dimer states to reduced monomer states 
50 after addition of reducing agent TCEP. (b) Quantitative 
analysis showing the fraction (□) of dimer and monomer 
states as a function of reaction time. ( c) Current blockage 
versus dwell time distribution over the course of reaction 
time. Applied voltage: 50 m V; Buffer: 1 M KC!, 5 mM 
55 HEPES, pH 8. (d) Quantitative analysis showing the reac-
tion quotient Qr as a function of reaction time. 
60 
FIG. 7: Assembly of SPPl gp6 subunits into 12 subunit 
connector complexes as shown by 15-35% glycerol gradient 
ultracentrifugation. BSA was used for size control. 
BRIEF DESCRIPTION OF THE SEQUENCE 
LISTING 
SEQ ID NO: 1 is the nucleic acid sequence of a nucleotide 
65 encoding a wild type SPPl connector channel polypeptide. 
SEQ ID NO: 2 is the amino acid sequence of a wild type 
SPPl connector channel polypeptide. 
US 10,648,966 B2 
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SEQ ID NO: 3 is the nucleic acid sequence of a nucleotide 
encoding an exemplary SPPl connector channel polypeptide 
variant. 
8 
sequence identity. In calculating percent sequence identity, 
two sequences are aligned and the number of identical 
matches of nucleotides or amino acid residues between the 
two sequences is determined The number of identical SEQ ID NO: 4 is the amino acid sequence of the exem-
plary SPPl connector channel polypeptide variant encoded 
by the nucleotide of SEQ ID NO: 3. 
SEQ ID NO: 5 is the nucleic acid sequence of a nucleotide 
encoding another exemplary SPPl connector channel poly-
peptide variant. 
SEQ ID NO: 6 is the amino acid sequence of the exem-
plary SPPl connector channel polypeptide variant encoded 
by the nucleotide of SEQ ID NO: 5. 
5 matches is divided by the length of the aligned region (i.e., 
the number of aligned nucleotides or amino acid residues) 
and multiplied by 100 to arrive at a percent sequence identity 
value. It will be appreciated that the length of the aligned 
region can be a portion of one or both sequences up to the 
10 full-length size of the shortest sequence. It will be appreci-
ated that a single sequence can align differently with other 
sequences and hence, can have different percent sequence 
identity values over each aligned region. It is noted that the 
percent identity value is usually rounded to the nearest 
SEQ ID NO: 7 is the nucleic acid sequence of a nucleotide 
encoding another exemplary SPPl connector channel poly-
peptide variant. 
SEQ ID NO: 8 is the amino acid sequence of the exem-
plary SPPl connector channel polypeptide variant encoded 
by the nucleotide of SEQ ID NO: 7. 
15 integer. 
SEQ ID NO: 9 is the nucleic acid sequence of a nucleotide 
encoding another exemplary SPPl connector channel poly-
peptide variant. 
SEQ ID NO: 10 is the amino acid sequence of the 
exemplary SPPl connector channel polypeptide variant 
encoded by the nucleotide of SEQ ID NO: 9. 
The alignment of two or more sequences to determine 
percent sequence identity is performed using the algorithm 
described by Altschul et al. (1997, Nucleic Acids Res., 
25:3389-3402) as incorporated into BLAST (basic local 
20 alignment search tool) programs, available at ncbi.nlm.nih-
.gov on the World Wide Web. BLAST searches can be 
performed to determine percent sequence identity between a 
first nucleic acid and any other sequence or portion thereof 
aligned using the Altschul et al. algorithm. BLASTN is the 
25 program used to align and compare the identity between 
nucleic acid sequences, while BLASTP is the program used 
to align and compare the identity between amino acid 
sequences. When utilizing BLAST programs to calculate the 
percent identity between a sequence disclosed herein (e.g., 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
30 SEQ ID NOs: 1-10) and another sequence, the default param-
eters of the respective programs are used. 
The details of one or more embodiments of the presently-
disclosed subject matter are set forth in this document. 
Modifications to embodiments described in this document, 
and other embodiments, will be evident to those of ordinary 
skill in the art after a study of the information provided in 
this document. The information provided in this document, 
and particularly the specific details of the described exem- 35 
plary embodiments, is provided primarily for clearness of 
understanding and no unnecessary limitations are to be 
understood therefrom. In case of conflict, the specification of 
this document, including definitions, will control. 
The presently-disclosed subject matter includes, in some 40 
embodiments, a nucleic acid molecule encoding an SPPl 
connector polypeptide variant. The SPPl connector poly-
peptide variant can comprises an amino acid sequence 
having at least 90, 91, 92, 93, 94, 95, 96, 97, or 99% 
sequence identity to a sequence shown in SEQ ID NO:4, 45 
SEQ ID NO:6, SEQ ID NO:8, or SEQ ID NO:10. In some 
embodiments, the nucleic acid molecule encodes a SPPl 
connector polypeptide variant comprising an amino acid 
sequence as set forth in SEQ ID NO:4, SEQ ID NO:6, SEQ 
ID NO:8, or SEQ ID NO:10. In some embodiments, the 50 
nucleic acid molecule has the sequence shown in SEQ ID 






















Conservative Amino Acid Substitutions 
Representative Conservative Amino Acids 
Ser, Gly, Cys 
Lys, Gln, His 
Gln, His, Glu, Asp 
Glu, Asn, Gln 
Ser, Met, Thr 
Asn, Lys, Glu, Asp, Arg 
Asp, Asn, Gln 
Pro, Ala, Ser 
Asn, Gln, Lys 
Leu, Val, Met, Ala 
Ile, Val, Met, Ala 
Arg, Gln, His 
Leu, Ile, Val, Ala, Phe 
Met, Leu, Tyr, Trp, His 
Thr, Cys, Ala 
Ser, Val, Ala 
Tyr, Phe 
Trp, Phe, His 
Ile, Leu, Met, Ala, Thr 
Modifications, including substitutions, insertions or dele-
tions are made by known methods. By way of example, 
modifications are made by site-specific mutagenesis of 
nucleotides in the DNA encoding the protein, thereby pro-
ducing DNA encoding the modification, and thereafter 
expressing the DNA in recombinant cell culture. Techniques 
for making substitution mutations at predetermined sites in 
DNA having a known sequence are well known, for example 
M13 primer mutagenesis and PCR mutagenesis. 
The presently-disclosed subject matter further includes, in 
some embodiments, a SPPl connector polypeptide variant 
comprising an amino acid sequence having at least 90, 91, 55 
92, 93, 94, 95, 96, 97, or 99% sequence identity to a 
sequence shown in SEQ ID NO:4, SEQ ID NO:6, SEQ ID 
NO:8, or SEQ ID NO:10. In some embodiments, the SPPl 
connector polypeptide variant comprises an amino acid 
sequences as set forth in SEQ ID NO:4, SEQ ID NO:6, SEQ 60 
ID NO:8, or SEQ ID NO:10. In some embodiments, the 
SPPl connector polypeptide variant comprises an amino 
acid sequence encoded by a nucleic acid molecule having 
the sequence shown in SEQ ID NO:3, SEQ ID NO:5, SEQ The presently-disclosed subject matter further includes, in 
65 some embodiments, a conductive channel-containing mem-
brane, comprising (a) a membrane layer; and (b) a SPPl 
connector polypeptide variant that is incorporated into the 
ID NO:7, or SEQ ID NO:9. 
A nucleic acid or polypeptide sequence can be compared 
to another sequence and described in terms of its percent 
US 10,648,966 B2 
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membrane layer to form an aperture through which conduc-
tance can occur when an electrical potential is applied across 
the membrane, wherein the SPPl connector polypeptide 
variant is selected from among those disclosed herein. 
10 
other embodiments the incorporated SPPl connector poly-
peptide variant is mobile in the membrane layer. In certain 
other embodiments the conductive channel-containing 
membrane is capable oftranslocating double-stranded DNA 
5 through the aperture when the electrical potential is applied. Embodiments described herein find use in a variety of 
molecular analytical contexts, including, for example, sen-
sitive detection and characterization of chemical and bio-
chemical analytes for biomedical, clinical, industrial, chemi-
cal, pharmaceutical, environmental, forensic, national 
security, toxicological and other purposes, including any 
situation where rapid, specific and exquisitely sensitive 
detection and/or characterization of an analyte ( e.g., prefer-
ably a soluble analyte that is provided in solution) may be 
desired. Expressly contemplated are embodiments in which 
the presently disclosed compositions and methods are used 
for DNA sequencing, including dsDNA sequencing, high-
throughput DNA sequencing, genomics, SNP detection, 
molecular diagnostics and other DNA sequencing applica-
tions, and polypeptide detection and identification. Addi-
tional utilities include those described in International Patent 20 
Application Publication No. WO2010/062697, which is 
incorporated herein in its entirety by this reference. 
In certain other embodiments the conductive channel-con-
taining membrane is capable of translocating polypeptides 
through the aperture when the electrical potential is applied. 
In certain embodiments conductance occurs without voltage 
10 gating when the electrical potential is applied. 
In some embodiments, the SPPl connector polypeptide 
variant comprises a detectable label. In some embodiments, 
the detectable label is selected from the group consisting of 
a colorimetric indicator, a GCMS tag compound, a fluores-
15 cent indicator, a luminescent indicator, a phosphorescent 
indicator, a radiometric indicator, a dye, an enzyme, a 
substrate of an enzyme, an energy transfer molecule, a 
quantum dot, a metal particle and an affinity label. 
While the terms used herein are believed to be well 
understood by those of ordinary skill in the art, certain 
definitions are set forth to facilitate explanation of the 
presently-disclosed subject matter. 
Unless defined otherwise, all technical and scientific 
terms used herein have the same meaning as is commonly 
understood by one of skill in the art to which the invention(s) 
belong. 
All patents, patent applications, published applications 
and publications, GenBank sequences, databases, websites 
and other published materials referred to throughout the 
entire disclosure herein, unless noted otherwise, are incor-
porated by reference in their entirety. 
Where reference is made to a URL or other such identifier 
or address, it understood that such identifiers can change and 
particular information on the internet can come and go, but 
equivalent information can be found by searching the inter-
net. Reference thereto evidences the availability and public 
dissemination of such information. 
As used herein, the abbreviations for any protective 
groups, amino acids and other compounds, are, unless 
Exemplary analytes thus include nucleic acids such as 
DNA and RNA (including dsDNA and dsRNA), including 
for the detection and identification of single nucleotide 25 
polymorphisms (SNPs) and/or mutations in such nucleic 
acids, and/or nucleic acid sequence determination. Other 
exemplary analytes that may be detected and/or character-
ized using the herein described compositions and methods 
include polypeptides and other biopolymers (e.g., proteins, 30 
glycoproteins, peptides, glycopeptides, oligosaccharides, 
polysaccharides, lipids, glycolipids, phospholipids, etc.) and 
other biomolecules (e.g., soluble mediators, cofactors, vita-
mins, bioactive lipids, metabolites, and the like), drugs and 
other pharmaceutical and pharmacological agents, including 35 
natural and synthetic compounds, food and cosmetics agents 
such as flavorants, odorants, preservatives, antioxidants, 
antimicrobial agents, stabilizers, carriers, excipients, modi-
fying agents and the like, natural and synthetic toxins, dyes, 
and other compounds. 
Accordingly and in certain embodiments, any analyte for 
which detection and/or characterization is desired may be 
used, where it will be recognized from the disclosure herein 
that the analyte is preferably soluble in a solvent that does 
not compromise the integrity of the particular membrane 45 
layer in which the SPPl connector polypeptide variant is 
incorporated to form an aperture through which conductance 
can occur when an electrical potential is applied across the 
membrane. Analyte selection may thus vary as a function of 
the composition of the particular membrane layer being 50 
used, which may therefore influence solvent selection. 
Those skilled in the art will be familiar with criteria to be 
employed for selecting a solvent that is compatible with a 
membrane layer of any particular composition. In preferred 
embodiments, the membrane layer comprises a phospholipid 
bilayer and the solvent in which the analyte is provided 
comprises an aqueous solvent, e.g., a solvent that comprises 
water. 
40 indicated otherwise, in accord with their common usage, 
recognized abbreviations, or the IUPAC-IUB Commission 
on Biochemical Nomenclature (see, Biochem. (1972) 11(9): 
1726-1732). 
In some embodiments of the conductive channel-contain-
ing membrane, the membrane layer comprises a lipid layer. 
In a further embodiment the lipid layer comprises amphip-
athic lipids, which in certain still further embodiments 
comprise phospholipids and the lipid layer comprises a lipid 
bilayer. In certain other embodiments the lipid layer is 
selected from a planar membrane layer and a liposome. In 
certain embodiments the liposome is selected from a mul-
tilamellar liposome and a unilamellar liposome. In certain 
Although any methods, devices, and materials similar or 
equivalent to those described herein can be used in the 
practice or testing of the presently-disclosed subject matter, 
representative methods, devices, and materials are described 
herein. 
In certain instances, nucleotides and polypeptides dis-
closed herein are included in publicly-available databases, 
such as GENBANK® and SWISSPROT. Information 
including sequences and other information related to such 
nucleotides and polypeptides included in such publicly-
available databases are expressly incorporated by reference. 
55 Unless otherwise indicated or apparent the references to 
such publicly-available databases are references to the most 
recent version of the database as of the filing date of this 
Application. 
The present application can "comprise" ( open ended) or 
60 "consist essentially of' the components of the present inven-
tion as well as other ingredients or elements described 
herein. As used herein, "comprising" is open ended and 
means the elements recited, or their equivalent in structure 
or function, plus any other element or elements which are 
65 not recited. The terms "having" and "including" are also to 
be construed as open ended unless the context suggests 
otherwise. 
US 10,648,966 B2 
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Following long-standing patent law convention, the terms 
"a", "an", and "the" refer to "one or more" when used in this 
application, including the claims. Thus, for example, refer-
ence to "a cell" includes a plurality of such cells, and so 
forth. 
Unless otherwise indicated, all numbers expressing quan-
tities of ingredients, properties such as reaction conditions, 
and so forth used in the specification and claims are to be 
understood as being modified in all instances by the term 
"about". Accordingly, unless indicated to the contrary, the 
numerical parameters set forth in this specification and 
claims are approximations that can vary depending upon the 
desired properties sought to be obtained by the presently-
disclosed subject matter. 
As used herein, the term "about," when referring to a 
value or to an amount of mass, weight, time, volume, 
concentration or percentage is meant to encompass varia-
tions of in some embodiments ±20%, in some embodiments 
±10%, in some embodiments ±5%, in some embodiments 
±1%, in some embodiments ±0.5%, and in some embodi-
ments ±0.1 % from the specified amount, as such variations 
are appropriate to perform the disclosed method. 
As used herein, ranges can be expressed as from "about" 
one particular value, and/or to "about" another particular 
value. It is also understood that there are a number of values 
disclosed herein, and that each value is also herein disclosed 
as "about" that particular value in addition to the value itself. 
For example, if the value "10" is disclosed, then "about 10" 
is also disclosed. It is also understood that each unit between 
12 
channels with a pore size of only around 1.2-nm, which is 
too small to allow passage of protein or peptides that are 
typically in multiple nanometers scale. To acquire protein 
channels with larger pore sizes, we reengineered a robust 
5 portal channel from bacteriophage SPPl that allowed the 
translocation of peptides with higher ordered structure to 
produce clear and reproducible electron signatures. By com-
bining optical single molecule microscopy with resistive 
pulse technologies, we observed translocation of peptides 
10 quantitatively and analyzed their conformation and dynamic 
folding in real-time at single molecule level. The secondary 
structure and conformation, such as the oxidative and the 
reduced states, were directly and clearly differentiated. A 
similar !i.G0 was obtained when different concentrations of 
15 substrates were applied, suggesting that the use of SPPl 
nanopore for real-time quantification of peptide folding is 
feasible. With the intrinsic nature of size and conjugation 
amenability, this SPPl nanopore has the potential for devel-
opment into a tool for the quantification of protein structure 
20 and folding in real time. 
Living systems contain wide varieties of nanomachines 
with diverse structures and functions. The ingenious design 
of viral DNA packaging motors and their intriguing mecha-
nism of action has provoked a wide range of interests among 
25 scientists in many different areas1 - 5 . Tailed bacteriophages 
are viruses that infect and reproduce within a bacterium, and 
widely exist in the biosphere. The portal protein is one of the 
essential components of the viral packaging motors with a 
two particular units are also disclosed. For example, if 10 30 
and 15 are disclosed, then 11, 12, 13, and 14 are also 
disclosed. 
turbine-like shape6 • 7 . SPPl is a dsDNA phage that infects 
Bacillus subtilis. The DNA packaging motor of SPPl con-
sists of a terminase composed of small (gpl) and large (gp2) 
subunits, portal protein gp6, and a two head completion 
proteins gp15 and gpl68 • 9 that powers the encapsulation of 
45.9 kbp genomic DNA10. The central core of the SPPl 
As used herein, "optional" or "optionally" means that the 
subsequently described event or circumstance does or does 
not occur and that the description includes instances where 
said event or circumstance occurs and instances where it 
does not. For example, an optionally variant portion means 
that the portion is variant or non-variant. 
Although any methods, devices, and materials similar or 
equivalent to those described herein can be used in the 
practice or testing of the presently-disclosed subject matter, 
representative methods, devices, and materials are now 
described. 
The presently-disclosed subject matter is further illus-
trated by the following specific but non-limiting examples. 
The following examples may include compilations of data 
that are representative of data gathered at various times 
during the course of development and experimentation 
related to the present invention. 
EXAMPLES 
Example 1 
Nanopore of SPPl DNA Packaging Motor for 
Dynamic Analysis of Protein Conformation and 
Folding in Real Time 
35 motor is a portal channel, termed connector, which is 
composed of 12 or 13 copies of protein gp69 • 11 Explicit 
engineering of the SPPl portal protein is possible due to its 
available crystal structure12• 13 . The connector has an overall 
diameter of 16 nm and a height of 10.5 nm. The narrowest 
40 constriction of the internal channel is -3 nm (FIG. 1)12• 13 • 
Nanopore technology has recently emerged as a real-time 
and high-throughput single molecule detection method, 
holding great potential for sensing a wide range of analytes, 
molecular diagnostics and DNA sequencing applications14-
45 23. Solid state nanopores generated by microfabrication 
generally have less reproducible pore sizes and lack chemi-
cal and location selectivity. Protein nanopores harvested in 
bacteria are homogenous in size and can be functionalized 
with probes, but commonly used nanopores derived from 
50 ion channels have an internal channel diameter of only -1.2 
nm24- 27 . In search for alternative larger sized protein chan-
nels, we have previously developed membrane-embedded 
phi29 motor channels28-30 for single molecule sensing of 
nucleic acids28 • 29• 31 -34, chemicals35 , or binding assays of 
55 antibody based on channel conformational change31 • 36 . 
Herein, we reengineered the SPPl connector and inserted it 
into a lipid bilayer to serve as a robust nanopore for 
detecting the translocation and conformational dynamics of 
Information about conformation and folding of proteins 
can convey biological functions. A simple method to replace 60 
conventional sophisticated and labor-intensive methodology 
peptides and proteins at single molecule level. 
Elucidating the structural conformation and folding of 
proteins and peptides is critical for understanding their 
biological functions. A wide range of biophysical methods, 
such as X-ray crystallography, NMR, Circular Dichroism, 
Dual Polarization Interferometry, and Mass Spectrometry 
to detect protein conformation and kinetic folding in real 
time is desirable. While nanopore technology has become a 
powerful tool in single molecule sensing, protein nanopore 
appears more advantageous concerning channel amenabil-
ity, structure homogeneity, and production reproducibility. 
However, most of the well-studied protein nanopores are ion 
65 have been used to investigate folding and dynamic structural 
changes of proteins. However, these methods require expen-
sive instrumentation and specialized labor. Nanopores offer 
US 10,648,966 B2 
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an attractive alternative as they are intrinsically single 
molecule in nature requiring ultra-low sample volumes, are 
label free, amplification free, and function using a simple 
detection process requiring no specialized expertise. While 
the translocation of DNA and RNA have been studied 5 
extensively in biological nanopores 14• 16• 24• 37 , studies on 
translocation of protein or peptides have just been emerged. 
This is mainly due to the size limitation of the commonly 
used protein pores, which are not large enough to allow the 
passage of proteins. The proteome can be an accurate and 10 
direct indicator of current health status of patients38 . For 
example, early diagnosis and monitoring the changes of 
amyloid-~ peptide and a-synuclein are critical for the man-
agement of Alzheimer's and Parkinson's disease39 . 
A handful of studies demonstrating peptide translocation 15 
using nanopores have been published, but 
quantitative analysis and translocation validation remain 
challenging40-47 , since there is no technique available for 
amplifying protein substrates as in DNA or RNA qualifica-
tion using PCR48 . The availability of only trace amounts of 20 
peptide or protein for analysis after translocation is far 
beyond the sensitivity threshold of classical protein detec-
tion methods. In this report, we combined single molecule 
fluorescence microscopy and resistive pulse technique to 
quantitatively study peptide translocation through SPPl 25 
connectors and elucidate the structural conformations of 
14 
Occasionally -400 pA current jumps were observed, attrib-
uted to simultaneous insertion of two connectors. The aver-
age conductance of reengineered SPPl connectors is 
4.27±0.27 nS (FIG. 2b). The conductance is uniform without 
displaying any voltage gating phenomena under the reported 
conditions of ±50 mV (FIG. 2c). 
Characterization of Peptide Translocation Through Reen-
gineered SPPl Connector 
A positively charged 12 amino acid TAT peptide was used 
in the translocation studies with sequence Cys-Tyr-Gly-Arg-
Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg. Due to the presence of 
cysteine at the N-terminus, the peptide forms a dimer by 
disulfide bond under physiological conditions, which is 
confirmed by mass spectroscopy. In the absence of peptide, 
the current trace was quiescent. In contrast, when the peptide 
was premixed with the conducting buffer in both cis- and 
trans-chambers, a burst of transient blockage events were 
observed immediately after the insertion of connector in the 
lipid membrane (FIG. 3a). As the peptide concentration was 
increased from 1.25, 2.5, 3.75, to 5 µg/mL, the density of 
current blockage events increased with a corresponding 
linear increase in peptide translocation rate from 2.33±1.54, 
7.5±1.66, 10.17±3.58, to 16.96±6.01 events per second 
(FIG. 3b). One parameter used to characterize the translo-
cation was the current blockage percentage, calculated as the 
ratio of current blockade resulting from peptide transloca-
tion to the open current of one portal channel, expressed as 
[(l-Currentpeptide)/Currentopen_channezl. The distribution of 
current blockage was relatively broad with a major peak at 
peptides at the single molecule level. This new nanopore 
peptide sensing technology with explicit engineering capa-
bilities has the potential to transform the proteomics field, 
including future biomarker analysis, early disease diagnosis 
and even protein sequencing. 
Results 
Characterization of SPPl Reengineered Nanopore 
Embedded in a Lipid Bilayer 
30 -55.1±3% (FIG. 3c). Another parameter was the dwell time 
(t), the time taken for the peptide to traverse from one end 
of the connector to the other end. The dwell time distribution 
followed an exponential decay with a rate constant of 
0.84±0.09 s- 1 (FIG. 3d). 
Quantitative Validation of Peptide Translocation by 
Single Molecule Fluorescence Imaging 
To validate the translocation of peptide through SPPl 
connector, we conducted single molecule fluorescence 
imaging of samples collected from patch clamp experi-
Structural analysis revealed that the central region of the 35 
SPPl connector shows slight hydrophobicity compared with 
the flanking regions at the N- and C-terminal ends which are 
more hydrophilic (FIG. la-b). To facilitate SPPl connector 
purification, a 6xHis-tag (SEQ ID NO: 11) was inserted at 
the C-terminal end along with a 6xglycine linker fSEQ ID 
NO: 12) for end-flexibility. The presence of His-tag 
enhanced the hydrophilicity of the C-terminal, thus making 
the hydrophilichydrophobichydrophilic layers more distinct, 
which is necessary to mimic the lipid bilayer architecture. 
After His-tag colunm purification, the purified protein was 
further purified by 15-35% glycerol gradient ultracentrifu-
gation to verify whether SPPl subunit could assemble into 
the channel complex (FIG. 7). Bovine serum albumin (BSA) 
with molecular weight of 60 KDa, which is almost equal to 
40 ments. HPLC purified Cy3 conjugated TAT peptide at a final 
concentration of 2.5 ng/µL was added to the cis-chamber 
after stable insertion of SPPl connectors in the lipid bilayer. 
Under an applied negative trans-membrane voltage, the 
positively charged peptide translocated through the portal 
45 channel to the trans-chamber. 50 µL samples were collected 
from the trans-chamber at 0, 20, 40, and 60 minutes after 
addition of Cy3-TAT peptide and loaded onto glass cover-
slips. The positively charged peptide bound to the negatively 
charged glass surface through charge-charge interactions 
a single subunit (58 KDa) of the SPPl connector, centered 50 and appeared as individual fluorescent spots (FIG. Sa). 
at fraction 27, whereas the SPPl portal complex was at 
fraction 17, indicating the formation of higher molecular 
weight complex. 
Fluorescence imaging revealed that the number of Cy3 spots 
in the field of view increased over the time course of 60 mins 
(FIG. Sb). In contrast, in a control experiment under the 
same conditions but in the absence of portal channel, very 
55 few Cy3 spots were observed, compared to the sample 
containing SPPl connector (FIG. Sb). Since TAT is a mem-
brane penetrating peptide, it is conceivable that a small 
fraction could potentially pass through the lipid bilayer, 
contributing to the small increase in the fluorescence back-
To incorporate SPPl portal channel into planar lipid 
membranes, a two-step procedure was employed28 . The 
connector was first reconstituted into liposomes and then the 
liposome-connector complex was fused with a planar lipid 
membrane. Direct incubation of the connector or liposome 
alone with a planar lipid bilayer did not result in connector 
insertion into the lipid bilayer. Single channel conductance 
assay was performed to measure the electrophysiological 
properties of membrane-embedded SPPl connectors. The 
connector insertion steps were observed as distinct stepwise 
increase in conductance as revealed in a continuous current 
trace (FIG. 2a ). The insertion of single portal channel results 65 
in -200 pA in current jump under an applied potential of 50 
mV in conducting buffer (1 M KC!, 5 mM HEPES, pH 8). 
60 ground signal. 
Kinetic Analysis of TAT Conformational Status in Real 
Time 
The focus of this study was to investigate whether the 
large and robust SPPl motor nanopore can be used for 
kinetic analysis of protein folding in real time. TAT peptide 
with and without a cysteine was used as a model system to 
study conformational changes. Structural analysis of TAT 
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sequence using the computer program PEP-FOLD49 
revealed that without forming disulfide bond, the TAT only 
adopts one a-helical conformation (FIG. 4). However, in the 
presence of a cysteine at the N-terminus, the peptide can be 
oxidized into a dimer by forming a disulfide bond between 5 
two N-terminal cysteines and exhibiting two parallel a-he-
lices. The presence of two states, the oxidized and the 
reduced conformations, were confirmed by translocation 
studies with the SPPl portal channel. Under an oxidized 
state, the current blockage distribution by TAT displayed a 10 
major peak, centered at 55.1±3% (FIG. 4a), with a minor 
peak centered at 28.5±1.9%. However, after adding the 
reducing agent TCEP [(tris(2-carboxyethyl)phosphine)] to 
16 
and the reaction quotient 
j [TAT]2*[0-TCEP] 
Q,lQr= [TAT-TAT]*[TCEP]' 




break the disulfide bond, the blockage distribution signifi- 15 prior to adding TCEP) portion of TAT monomer at the 
cantly changed. The peak of 55.1±3% decreased signifi- beginning, the equation was solved to obtain the following 
cantly with time, while the majority of the blockade distri-
bution shifted to 28.5±1.9%. This indicated that most of the 
peptide passing through the channel is in its single a-helical 
conformation (FIG. 4b ). Current blockage distribution of the 20 
reduced TAT peptide was similar to Cy3-TAT signature with 
TCEP treatment, since the conjugation of Cy3 prevented the 
disulfide bond formation and resulted in similar blockage, 
representing the single TAT helix (FIG. 4c). 
equation: 
y = ( Nk ( ,2 )) 2exp 
1 5 
exp - - - 1 + E: 
(4nD) · fl 5 4Dt 
2(1-yJ'ct 
Q, = yCr(l +y)2. 
(2) 
(3) 
To quantify the kinetics parameter, we further examined 25 
the conformational changes of TAT peptide upon addition of 
TCEP and recorded the change of the current blockage 
profile in real time (FIG. 6). The current blockade signature 
progressively shifted from predominantly 55.1±3% to 
28.5±1.9%, representing the real-time kinetic process of 
disulfide bond reduction (FIG. 6a). To derive the kinetic 
parameter of this reaction process, two parameter y ( defined 
as the ratio of the number of peak A versus the sum of A and 
C(t) is the equilibrium TCEP concentration. To evaluate 
whether the parameters derive from this real time quantifi-
30 cation analysis represent the real parameters of the reaction, 
the ti.Ge value were determined from different assays using 
constant TAT but varied concentration of TCEP from 100, 
250, 500 µM, and compared with the ti.Ge derived by 
conventional methods. 
The red line in FIG. 6b is the fitting curve with equation 
(2) and Qr in FIG. 6d is derived from y with equation (3). 
B) and reaction quotient Qr were determined (FIGS. 6b, d). 
The transition of y and Qr as shown in FIGS. 6b and Sd 35 
represents the timely evolution of the reduction reaction. 
The y and Qr is theoretically derived by applying second-
order reaction dynamics and diffusion model, as follows: When the reaction approaches equilibrium, Qr is equal to 
standard equilibrium constant Ke. From FIG. 6d, Ke is 
40 
H20 
TAT-TAT+ TCEP----,2TAT + O-TCEP 
Co C(t) 0 0 
C, C(t) - (Co - C,) 2(C0 - C,) C0 - C, 
dC, - = -kC,[C(t)-(Co -C,)], 
dt 
since C(t) » Co, 
then, C, = Co* exp(-kC(t)t) 
(1) 
C(t) is the TCEP concentration at the pore entrance. Accord-
ing to diffusion equation, C(t) has the following form: 
N ( ,
2 
) C(t) = ---exp -- . 
(4nDt)l.5 4Dt 
estimated to be 1.4x104 and corresponding to -23.3 kJ/mol 
Gibbs free energy (ti.Ge). 
As shown in FIG. 6b, y decreased over the course of 
reaction time, indicating the decrease in oxidized dimer 
45 conformation and concurrent increase in reduced mono-
meric state. Fitting the data to a single exponential function 
revealed a rate constant, k=0.989±0.096 min-1 and 
t0=5.2±0.04 min. The trend is also demonstrated in current 
50 blockage percentage versus dwell time distribution of events 
over the course of the reaction time (FIG. 6c ). All the data 
from different concentrations ofTCEP, show the same trends 
to approach equilibrium status. The related Ke and ti.Ge are 
55 
depicted in table 1. 
In order to study the TAT reduction process quantitatively, 60 
we calculated the ratio 
The assay revealed that, when different concentration of 
TCEP were used, the ti.Ge were very similar (Table 1). 
When the concentration of TCEP was increased from 100, 
250, to 500 µM µM, the ti.Ge were -24.5, -23.1, and -23.3 
kJ/mol respectively. The similarity of the ti.Ge derived from 




that using SPPl nanopore for real time quantification of 
peptide folding is feasible. In addition, ti.Ge derived from 
65 these experiments is very close to the ti.Ge of -27 kJ/mol for 
disulfide bond in protein obtained by conventional meth-
ods50. 
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TABLE 1 
Parameters for the quantification of dynamic 
folding of TAT peptide in real time 
TAT concentration TCEP concentration Qr Ke 
(nM) (µM) (103 ) (103) 
300 100 26.6 26.6 
300 250 11.8 11.8 







In this study, we showed that the SPPl portal channel can 
be successfully incorporated into planar lipid bilayer to 
serve as a nanopore with robust electrophysiological prop-
erties. With a conductance of 4.27 nS, it is one of the larger 
channels and only the second viral protein channel (apart 
from phi29 connector)28 to be incorporated into a lipid 
membrane. In the presence of TAT peptide, a burst of current 
blockage events with characteristic current amplitude and 
dwell time were observed indicating the translocation of the 
peptides through the SPPl connector. This was further 
validated by single-molecule fluorescence imaging. The 
oxidized and reduced conformations of TAT peptide can be 
clearly distinguished in real time. The results demonstrate 
the potentials of nanopore-based proteomics. 
Direct evidence of DNA translocation through a-hemoly-
sin was demonstrated twenty years ago by quantitative 
PCR51 . Although a handful of studies utilizing peptide and 
protein translocation through nanopore, have been published 
over the last several years including protein folding, unfold-
ing, stability and disease detection41 • 44• 45 • 52- 61 . Here, we 
developed a very simple method to provide evidence of 
peptide translocation using single molecule fluorescence 
imaging of samples obtained from the nanopore setup. This 
method can be easily adapted and employed by other 
laboratories to prove protein translocation and quantitatively 
study peptide translocation through nanopores. 
In this study, we further demonstrated that this new 
protein nanopore is capable of detecting kinetics of TCEP 
mediated reduction of disulfide bond and demonstrating 
peptide conformational changes in real time. From FIG. 6, 
the frequency of dimer forms (-5 5%) decreased gradually to 
monomer forms (30% ), upon addition of TCEP, as the 
reaction time increased. Analyzing peptides and proteins is 
a complex task, since they fold into versatile and complex 
three dimensional structures composed of 20 building blocks 
compared to DNA or RNA with only 4 building blocks. 
Further improvements are necessary to develop the nano-
pore into a robust platform for proteomic profiling. The 
current blockage signature based on the translocation profile 
can be used to investigate the length, charge, hydrophobic-
ity, secondary structures and ultimately the amino acid 
sequences of the peptides. The kinetics of protein folding 
and unfolding as well as entropic and energetic contributions 
can be further dissected at the single molecule level. 
Conclusion 
A robust portal channel of bacteriophage SPPl has been 
reengineered and inserted into lipid bilayer to allow the 
translocation of peptides with higher ordered structure to 
produce clear and reproducible electron signatures. Optical 
single molecule fluorescence microscopy were combined 
with resistive pulse technologies to detect the translocation 
of peptides quantitatively and to analyzed their conforma-
tion and dynamic folding in real-time at single molecule 
level. The oxidative and the reduced conformation were 
clearly differentiated and their timely transition in the pres-
18 
ence of reducing agent were directly observed. When dif-
ferent concentrations of substrates were applied, a similar 
!i.G0 was obtained, suggesting that the use of SPPl nanopore 
for real-time dynamic quantification of peptide folding is 
5 feasible. 
Materials and Methods 
Materials: The phospholipid 1,2-diphytanoy l-sn-glycerol-
3-phosphocholine (DPhPC) was obtained from Avanti Polar 
Lipids, Inc. Organic solvents (n-decane and chloroform) 
10 were purchased from Fisher Scientific, Inc. and TEDIA, 
Inc., respectively. TAT peptide was custom-ordered from 
GenScript, Inc. All other reagents were purchased from 
Sigma or Fisher, if not specified. 
Cloning and Purification of the SPPl connector: Gene gp6 
15 encoding SPPl portal was synthesized and cloned into PET3 
vector between NhdeI and BamHI by GenScript, Inc. His-
tag was inserted into the C-terminal of the connector for 
purification. Then the plasmid was transformed into BL21 
(DE3) for expression and purification. The purification pro-
20 cedure has been described previously28 •30 . Briefly, the trans-
formed bacteria were cultured in 10 mL LB medium over-
night at 37° C. The bacteria were transferred to 1 L of fresh 
LB medium. When the OD600 reached -0.5-0.6, 5 mM IPTG 
was added to the medium to induce protein expression. The 
25 bacteria were collected by centrifugation after 3 hours 
continuous culture. Bacteria was lysed by passing through 
French press. Lysed cell was separated by centrifugation and 
supernatant containing expressed protein was collected. The 
supernatant was purified with Nickel affinity chromatogra-
30 phy (Novagen)62 . His Binding Buffer (15% glycerol, 0.5 M 
NaCl, 5 mM Imidazole, 10 mMATP, 50 mM Tris-HCI, pH 
8.0), and the cleared lysate was loaded onto a His•Bind® 
Resin Colunm and washed with His Washing Buffer (15% 
glycerol, 0.5 M NaCl, 50 mM Imidazole, 50 mM Tris-HCI, 
35 pH 8.0). The His-tagged connector was eluted by His 
Elution Buffer (15% glycerol, 0.5 M NaCl, 0.5 M Imidazole, 
50 mM Tris-HCI, pH 8.0). The purified connector from 
chromatography was further purified by a 15-35% glycerol 
gradient ultracentrifugation at 35K for 2 hrs. Before incor-
40 porating into liposomes, the purified connector was dialyzed 
against buffer (0.5 M NaCl, 50 mM Tris-HCI, pH 8.0) to 
remove excess glycerol. 
Insertion of the connector into planar lipid bilayer: The 
protocol for the incorporation of connectors into lipid 
45 bilayer has been reported28- 31 • 63 . Briefly, planar bilayer lipid 
membranes (BLMs) were generated in a BCH- lA horizontal 
BLM cell (Eastern Scientific). A Teflon partition with a 200 
µm aperture was placed in the apparatus to separate the BLM 
cell into cis-(top) and trans-(bottom) compartments. A pla-
50 nar lipid bilayer was formed by painting the aperture with 
0.5 µL, of 3% (w/v) DPhPC in n-decane. A conducting 
buffer (1 M KC!, 5 mM HEPES, pH 7.8) was added to both 
the top and bottom compartments of the BLM cell, and 
Ag/AgCI electrodes were placed in the buffer of each 
55 compartment. The electrode in the trans-compartment was 
connected to the headstage of an Axopatch 200B amplifier 
(Axon Instruments, Inc.), and the electrode in the top 
compartment was grounded. Connector insertion was 
observed after addition of 1 µL of the diluted Liposome/ 
60 connector complex to the cis-compartment directly. 
Electrophysiological measurements: The headstage and 
Axopatch 200B patch clamp amplifier were connected to a 
DigiData 1440 analog-digital converter (Axon Instruments, 
Inc.) to monitor and record electrochemical currents through 
65 BLMs28-30 . The current recordings were low-pass filtered at 
a frequency of 1 or 5 kHz. The sampling frequency was 
20-200 kHz in all experiments, unless otherwise specified. 
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The data were recorded a with pClamp 9.1 software (Axon 
Instruments, Inc.), and analyzed with the Clampfit module 
ofpClamp 9.1 and OriginPro 8.1 (OriginLab Corporation). 
Peptide Translocation Experiments: TAT peptide (Cys-
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg (SEQ ID 
NO: 13)) with a final concentration of 23 µg/mL was 
premixed with the conducting buffer before the insertion of 
connector. For quantitative validation, Cy3 fluorophore was 
conjugated to TAT peptide by sulfhydryl-maleimide chem-
istry and purified by HPLC. Multiple channels were inserted 
into bilayer lipid membrane and then Cy3-TAT peptide was 
added into cis-chamber. Samples were collected from the 
trans-chamber after 0, 20, 40, and 60 min. 
20 
grated into the functional viral capsid72 . Based on the above 
mentioned models, a possible scenario of events during 
DNA translocation was discussed73 . There is a close inter-
action between the portal protein and DNA and such inter-
5 actions are independent of whether the viral ATPase itself 
performs the power stroke pushing the DNA into the capsid 
or whether portal protein apply the force to the DNA in 
response to conformational changes. Also, a 4-steps model 
for DNA gating ( a state from open state to closed state) was 
10 proposed74. During this model, the nascent prohead portal 
binds to the packaging proteins and then a conformational 
change causes termination of packaging and conformational 
switch. After the neck and tail assembly, DNA is delivered 
into the host. Single molecule fluorescence imaging: Samples collected 
from the patch clamp were incubated with the ozone pre- 15 
treated glass substrate for 10 min before imaging to ensure 
sufficient adsorption. A 532 nm green laser was used for the 
excitation of Cy3. A 60x objective (N.A.=1.4, oil immer-
sion) was used for fluorescence imaging. The signals were 
recorded using Andor iXon 887 V electron multiplied CCD 20 
camera. Images were taken with an exposure time of 500 ms. 
The number of spots in the images were counted using iSMS 
software 64 . 
The information encoded in DNA is the footing stone for 
the development of modem medicine and life sciences. The 
development of individualized medicine and related scien-
tific research has prompted the development of new kind of 
sequencing techniques beyond the original Sanger sequenc-
ing. As one of potential technologies, nanopore sequencing 
is one the rapidly sequence approaches which is expected to 
sequence a human genome for under $1000. So far, biologi-
cal nanopores have been used to study the transport of DNA 
and other molecules like DNA, RNA, chemical agents, 
Example 2 
Translocation of Double Strand DNA Through 
C-his SPPl Phage Nanomotor Embedded in Lipid 
Bilayer 
During the process of assembly of tailed bacteriophages, 
their genome is packaged within a preformed procapsid 
through a tunnel formed by the portal protein assembly. 
Such entropically unfavorable process is accomplished by 
an ATP-driven molecular motor. 65 -68 
For sppl bacteriophage, the molecular motor consists of 
three proteins: gpl, gp2 (ATPase) and gp6 (portal protein). 
Such cyclical homooligomers are located at a single vertex 
of the icosahedral viral capsid that binds to the tail. During 
the process of assembly, portal protein translocate double-
stranded DNA. After termination of packaging, portal pro-
tein is binded by head completion proteins (gp15 and gp16), 
which form a head-to-tail connector stereoscopic structure 
(Andrey A Lebedev, The EMBO Journal 2007). In common 
with the other herpesvirus portal protein 6 9 , the portal protein 
25 peptides, proteins and polymers75 - 79 . But due to the limita-
tion of pore dimension, most pores only allow small mol-
ecules and single-strand DNA or RNA, such as hemolysin 
and MSPA. a-haemolysin (a-HL) pore has been used to 
study the transportation of single DNA or RNA by using the 
30 transient blockade of ionic current. Bacteriophage phi 29 
motor, having a larger pore size of 3.6 nm, have highly 
widen nanopore biomedical applications for potential DNA 
sequencing. There are a variety of engineered phi 29 channel 
have been developed to detect dsDNA, ssDNA, chemical 
35 agents and even carcinogenic antigens80-83 . For bacterio-
phage spp 1 molecular motor, it has similar pore size of 3 .5 
nm which make it very suitable for dsDNA sequencing 
because dsDNA normally just have a diameter of about 2 
nm. However, the electrophysiological measurements of 
40 sppl connector channels for translocation of double strand 
DNA have not been reported so far. In this study, the wild 
type sppl connector was cloned and purified. After that, the 
connector was inserted into liposomes and lipid bilayer. 
dsDNA translocation was confirmed by single channel con-
45 ductance measurements and Q-PCR assay. Our study 
expands the future application of sppl nanopore in nano-
medicine and nanobiotechnology. 
of bacteriophage SPPl can exist as a circular assembly. The 
novelty and ingenious design of viral DNA packaging 
motors and their mechanism of action have provoked a 
broad range of interest among scientists in nanotechnology, 
biophysics. The genome of linear double-stranded DNA 50 
(dsDNA) virus is packaged into a preformed delicate pro-
capsid. 
Results 
Cloning and Purification of C-his sppl Connector 
To facilitate connector purification, a C-terminus was 
inserted with a poly histidine tag for improved affinity tag 
flexibility. The linker was included to provide end flexibility. 
After purified by his-tag affinity colunm, it was found that 
the C-his sppl connector self-assembled a unique 13-fold 
There exists debate about the molecular motor work 
mechanism of how each different component coordinate 
with each other. Hendrix proposed that DNA translocation is 
accompanied by rotation of portal protein based on the fact 
the low-energy barriers to rotation of symmetry mismatch-
ing protein rings relative to each other. Another models 
which involve the rotation of the portal protein DNA trans-
location is accompanied by sequential conformational 
changes propagating along the belt of tunnel loops with the 
porta protein70-71 . Also, the structure of the most constricted 
part of the internal loops which is expected to be in close 
contact with the DNA during translocation has been char-
acterized and defined. The portal protein has varying number 
of subunits: it exerts as a 13-subunit assembly in its isolated 
form but as a 12-subunit assembly active form when inte-
55 symmetric structure, which is compared with 12-fold in vivo 
active form, as observed by transmission electron micros-
copy. The existence of the motor configuration was demon-
strated through its ability to package the dsDNA into the 
procapsid and to assemble the resulting DNA-filled capsid 
60 into the infectious phi29 virion. 
Reconstituting the Connector into Liposomes 
A protocol for reconstituting the connector into liposomes 
was developed by co-incubation of the connector with the 
DOPC or DPhPC lipid and hydration-rehydration of the 
65 lipid film with proteolipsome containing the reengineered 
connector in the presence of sucrose. Such rehydration and 
co-incubation make the hydropobic layer of the connector 
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easier to interact with the hydrophobic domain of the lipid 
molecules. By such hydration-dehydration process, small 
unilamellar vesicles containing sppl connectors (50 µm) 
was developed. Fluorescence microscopy and sedimentation 
analysis was used to confirm the insertion of the connector 5 
protein into the lipid membrane. The presence of the con-
nector in the membrane was showed a clear florescent ring 
around the lipsome. While as a negative control, no fluo-
rescent ring was observed when fluorescently tagged con-
nector was mixed non-specifically with the non-connector 10 
inserted liposome. The free connectors were removed by 
5-20% sucrose gradient ultracentrifugation. 
Incorporating the Connector into Planar Lipid Mem-
branes 
The purified connector was then inserted into a planar 15 
lipid bilayer membrane (BLM). The insertion was demon-
strated by the discrete stepwise increase of the current. The 
number of the channels inserted can be counted by counting 
of the number of the stepwise. 
The step size of each current augment was almost iden- 20 
tical, representing the even and uniform structure and stoi-
chiometry. This was similar with the phi29 gpl0 connector 
channel, which also can formed quite uniform and even 
channels in the BLM75 • 79 . The channel conductance of the 
connector was compared with that of phi29 gpl0 using 25 
solutions of different ionic strength. Similarly, after a sta-
tistically analysis of conductance of two kinds of channel: 
wild type phi29 GPl0 connector and C-his sppl connector, 
two sharp Gaussian distribution was shown. Comparing to 
the conductance of phi29 gpl0 connector, sppl connector 30 
has a similar conductance of 4.4 ns in the presence of IM 
Kc!, 5 mM HEPES, representing that both sppl and phi29 
gpl0 connector has similar size. This can also be demon-
strated by the crystal structure of two connector 
proteins 70 • 79 . In addition, the channel demonstrate a per- 35 
fectly linear relationship with respect to the applied voltage 
of 50 m V. The spp 1 connector did not display voltage gating 
properties under the conditions described above but it 
showed gating at a higher voltage of 75 mV. 
22 
To calculate the dwell time (t) for DNA translocation 
events, only the blockade episodes greater than 30% were 
grouped as this percentage of blockade seemed consistent 
with the ratio of the cross-sectional area between dsDNA 
and the pore. It should also be noted that 8 (under 75 m V) 
individual outlying events which scattered from 100 ms to 
10000 ms were excluded in the graph for clarity. The dwell 
time distribution under 40 m V seemed broader than that 
under 75 mV. The average dwell time for DNA blockades 
under 75 mV was 14.6 ms. 
To verify the passage of dsDNA through the connector 
channels, quantitative polymerase chain (PCR) (Q-PCR) 
was used to quantify the translocation of 142-bp DNA under 
a voltage of 75 mV. DNA was added to the trans side and 
samples were taken from the cis side for quantification at 30 
minutes intervals. For comparison, control experiments 
were performed in the absence of connectors. 
The SPPl connector protein used in this example com-
prises the sequence of SEQ ID NO: 4. 
Example 3 
Translocation of Peptides Through 
Membrane-Embedded C-his SPPl Motor Protein 
Nanopores 
Living systems contain a wide range of nanomachines 
with diverse structures and functions. Tailed bacteriophages 
are a virus that infect and reproduce within a bacterium, and 
widely exist in the biosphere. Among the variety of bacterial 
viruses, viral connector protein is one of the essential 
components in packaging motor with turbine-like shape. 
SPPl is a dsDNA phage which infects Bacillus subtilis and 
the connector of SPPl is composed of portal protein gp6, 
and two head completion protein gp15 and gp16. 84• 85 The 
packaging motor of SPPl, which consist of gpl, gp2, and 
gp6, powers encapsulation of the 45.9 kb genome. 86The 
ingenious design of viral DNA packaging motors and the 
novel mechanism of action has provoked a wide range of 
Translocation of Double-Strand DNA 
In this report, both linear and circular plasmid were used 
to examine the translocation to examine the translocation of 
dsDNA through the connector channel. In the absence of 
linear DNA, the current trace was quiescent and only a quite 
small number of unspecific blockades were observed with a 
long time trace. But when dsDNA(142 bp) were added in to 
the cis chamber, numerous current blockades were observed, 
which led to the current jump of single connector insertion 
40 interest among scientists in many different areas. Although 
various portal proteins share little homology in primary 
sequence, and varies in size87- 89, they exhibit significant 
morphological similarity. Portal protein of SPPl and phi29 
share similar secondary structure and 3-D structure. Our 
45 recent research also found that they even share similar role 
in packaging genome91 -93 . Explicit engineering of the SPPl 
connector is possible due to its accessible crystal 
structure94• 95 . SPPl portal protein have 13-subunit form and 
the pseudoatomic structure with 12-subunits. The overall to be transiently reduced by 28-34%. When the voltage 
change to negative potential, the blockades cannot be 
observed. This implies that the connector exerts one-way 
traffic for dsDNA translocation, which is similar with one 
way traffic mechanism of phi29 gpl0 connector. When 
circular plasmid dsDNA was used, no translocation of the 
circular plasmid was observed. Interestingly, the same 55 
amount of circular plasmid was digested by DNase and then 
added into the chamber, a burst of transient blockades 
occurred. All the above results piles up to prove that only the 
linear dsDNA can pass through the connector channels. 
50 diameter of 13-subunit form is -1.65 nm, and the height is 
-1.10 nm. The narrow part is 2.77 nm in 13 subunit form and 
1.81 in 12 subunit form. 94• 95 
The blockade rates were affected by two factors: DNA 60 
concentration and transmembrane voltage. In the presence 
of 30 µM DNA under one channel insertion, the blockade 
rate was approximately 18 blockades per second. When the 
concentration of DNA placed in the chamber was doubled 
and tripled, the blockades frequency per second almost 65 
doubled and tripled. This implies that the blockades fre-
quency is direct proportion to the DNA concentration. 
Nanopore technology has recently emerged as a new 
real-time single molecule sensing method, holding a great 
potential to reduce the cost ofbiosensing and DNA sequenc-
ing. Over the last decade, the a-hemolysin (a-HL) and 
MspA channel has been expansively investigated for sensing 
and DNA translocation.96-99 Previously, we have success-
fully inserted phi29 connector channel from bacteriophages 
phi29 into lipid bilayer with robust properties. 100• 101 A 
one-way traffic property for dsDNA translocation with a 
valve mechanism for DNA packaging has also been 
observed.102 The reengineered connector channel is capable 
to discriminate single-strand DNA or RNA from double 
strand. By selectively engineering a probe on the connector, 
single chemicals and antibody can be identified based on 
their distinct fingerprints. 103 . The channel also exhibits 
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gating (a transition from an open state to a closed state) at 
higher trans-membrane potentials, a process that induces a 
conformational change in the channel subunits. 104 
The translocation of DNA and RNA have been studied 
24 
linear I-V relationship without display any voltage gating 
phenomenon under the reported conditions, 50 and 65 m V. 
The average conductance for a single channel was 2.06±0.08 
nS 50 mV in 1 M NaCl 5 mM HEPES pH 8. 
Translocation of Peptides Through C-his SPPl Connector 
Channels and Kinetic Study 
Several different peptides with various isoelectric point 
(PI) and length have been used to examine the translocation 
through SPPl connector channel, including poly histidine, 
10 poly lysine and CysTyrG!yArgLysLysArgArgG!nArgAr-
gArg(TAT) (SEQ ID NO: 13). In absent of peptide, the 
current trace was quiescent. Occasionally, unspecific block-
ades were detected with a minimum detectable time. Com-
extensively in other biological nanopores, such as the a-he- 5 
molysin, MsPA channel. 105 However, translocation of pro-
tein or peptide studies still have not attraction enough 
attention as it should be. Compared to the genome, the 
proteome is probably a much more accurate and direct 
indicator of the current health status of humans106 . For 
examples, early diagnosis and monitoring the change of 
amyloid-~ peptide is critical to the treatment of Alzheimer's 
and Parkinson's disease107 . However, proteiomic data prac-
tically when only trace amount of peptide or protein is 
present, is more difficult to acquire, because there is no 15 
amplified technique available for protein as DNA or RNA 
which can be readily amplified by the polymerase chain 
reaction108. In this report, we first time show that this 
reengineered SPPl reengineered motor channel has been 
successfully incorporated into plannar lipid bilayers, when 20 
reconstituted into liposomes, allows the translocation of 
various charged peptides with different level blockade. The 
peptides can be differentiated by the blockage of the chan-
nel. This engineered SPPl connector channel has potential 
for peptide or protein related diagnosis and sequencing in 25 
the future. 
pared with peptide translocation events, these unspecific 
blockades happened rarely. Buffer pH was adjusted accord-
ing to corresponding peptide pl to have peptide possessed 
positive charge in order to translocate through channel under 
voltage. A continuous current trace recording was shown 
before and after addition of peptide in real timee. Before 
TAT was added, the current trace was quiescent with occa-
sionally non-specific blockade events during long time 
recording time. Once TAT peptide was added to cis-chamber 
after X channel inserted into lipid bilayer, the blockage 
events was not immediately observed. After X minutes from 
the adding point, the blockade events gradually increased 
sparsely until reaching to a burst stage. This lagging time 
Results 
Characterization of C-his SPPl connector channel 
embedded into lipid bilayer Portal protein of SPPl and 
phi29 share high homology. Similarly to phi29 connector, 
the central surface region of SPPl portal protein also shows 
slight hydrophobicity compared with the two flanking layers 
at both ends, which are hydrophilic. To facilitate SPPl 
connector channel purification, a C-terminus his tag was 
inserted just downstream of a six-glycine linker for 
improved affinity tag flexibility. The linker was introduced 
to provide end flexibility. After purification to homogeneity, 
the molecular weight of single subunit of SPPl is 56 kDa as 
revealed in SDS PAGE gel, in agreement with theoretical 
molecular weight. To verify whether C-his SPPl subunit 
could assemble to complex correctly, 15-35% sucrose gra-
dient ultracentrifugation was performed. The fraction of 
bovine serum albumi (BSA) with molecular weight 60 KDa, 
is located at fraction 27, which represented single subunit of 
C-his SPPl connector, whereas the fraction of C-his SPPl 
portal protein shift to fraction 17, demonstrating high 
molecular weight complex has been formed. 
To incorporate C-his SPPl connector channel into planar 
lipid membranes, two step procedures which was also used 
in phi29 connector channel, was employed that the connec-
tor channel was first reconstituted into liposome first and 
then the liposome connector complex was fused into lipid 
membrane. Direct incubation of the connector channel or 
liposome with a planar lipid bilayer did not lead to channel 
insertion into the lipid bilayer. Single channel conductance 
assay was performed to measure the property of SPPl 
connector channel. The connector channel insertion was 
observed through a distinct stepwise increase in conduc-
tance. The insertion of single connector channel into lipid 
bilayer results in an approximately 200 pA in the current 
jump under a potential of 50 m V in 1 M KC! 5 mM HEPES 
pH 8. Occasionally 400 pA current jump was observed, 
attributed to two connector channels insertion. Similar 
results were also observed under different buffer condition 
between the adding point and the events showing up, indi-
cates the diffusion time from top of the solution to the nearby 
entrance of channel. In addition, the blockade events can 
30 only be observed under negative voltage, because the pep-
tide was only added to cis-chamber and positive charged 
peptide can only translocate from cis- to trans-chamber 
under negative voltage. When switch the polarity to positive 
voltage, there is no translocation events observed. In the 
35 same experiment, however, when small amount of buffer 
was transferred from cis-chamber to trans-chamber, the 
translocation events have been observed under positive 
voltage. However, the translocation rate is much lower than 
that under negative voltage due to the concentration of TAT 
40 in trans-chamber is much lower than cis-chamber. 
In comparison, when TAT peptide was premixed with 
buffer in both chamber before channel insertion, a burst of 
transient translocation events have been observed immedi-
ately after the first insertion occurred. One parameter used to 
45 characterize the translocation was the current blockage 
percentage, which represents the difference between the 
open connector channel and the reduced current caused by 
peptide translocation. Current blockage percentage was cal-
culated as follows: size of current blockage resulting from 
50 peptide translcocation to one connector channel divided by 
step size of the current for one connector insertion. 
The reduced current caused by TAT translocation is about 
115 or 170 pA, and the blockade has two major distributions, 
55±3% and 81±4% respectively. Translocation rate was 
55 influenced by peptide concentration. The current trance of 
single channel with different concentration of premixed TAT 
peptide under same time length. As the concentration 
increased from 1.25, 2.5 and 5 ug/ml, the density of block-
ade events has also increased correspondingly. The translo-
60 cation rate versus the concentration. As concentration 
increases from 1.25, 2.5, 3.75, 5 ug/ml, the translocation rate 
also increase linearly from 2.33±1.54, 7.5±1.66, 10.17±3.58, 
to 16.96±6.01 events per second. 
( data not shown). As comparison, the conductance of C-his 65 
SPPl connector channel was also measured under a scan-
Theoretical PI of poly lysine is about 9.7, therefore here 
we used 1 M KCL 5 mM Hepes, pH 8. When poly lysine 
peptide was added to the chamber, similar results have been 
observed but with different level of blockade. The current ning voltage. Uniform distribution of conductance under and 
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trace of single channel under IM KC! 5 mM Hepes, pH X, 
65 m V and as the concentration increase from 2 ug/ml to 20 
ug/ml, the translocation events increase dramatically. The 
reduced current is about and the blockade distribution is 
majored in 25%. 
Similar to other peptides, the blockade events have been 
observed after adding poly histidines. Because poly histidine 
theoretical PI is only 7.6, we used 1 M KCL 5 mM Hepes, 
pH 6 in the experiments to ensure poly histidines possessed 
positive charge. Under 50 mV, translocation events have 
been observed immediately when poly histidines was pre-
mixed with buffer in both chamber. Compared with TAT and 
poly lysine, the blockade is not uniform and the major 
blockage distribution is majored in X. As concentration 
increase from X to 18 ug/ml, the translocation rate increase 
linearly from X. 
Discussion 
In this study, we first time showed that C-his SPPl 
connector channel successfully has been incorporated into 
planar lipid bilayers when reconstituted into liposomes. 
Similar to phi29 connector channel, SPPl connector channel 
with a central tunnel plays crucial role during the DNA 
packaging or ejection 109 . Although the connector proteins of 
different phage have no similarity in the primary sequence, 
available electron microscopy data has shown that they all 
share a common turbine-like structure (Carrascosa, 2012). 
SPPl portal protein has 13-subunit in its isolated form, but 
26 
phi2987, T7114 and P2. 115 Both 12-mer and 13-mer assembly 
of SPPl connectors were obtained at different conditions94 . 
The mutations and modifications of these portal protein 
channels can be used to investigate and refine the nanopores 
5 for technical applications, such as DNA sequencing. 
Translocation of single-stranded DNA or RNA by bio-
logical or solid state nanopores has drawn great attention 
and has been well studied by several research groups, 
because of its importance in DNA sequencing and many 
10 other applications in recent years. 116- 119 Discrimination 
between single- and double-stranded nucleic acid molecules 
by translocating single-stranded homopolymers poly (A), 
poly (U), and poly (C) through solid state nanopore has been 
reported. 116 The translocation oflong random sequence and 
15 short length ssDNA through solid state nanopores has been 
characterized compared with the dsDNA and the hybrid 
DNA/RNA. 117• 118 The relatively large diameter of the 
connector channel is an ideal tool for studying double-
stranded DNA transport, 11 7 but detection of single-stranded 
20 nucleic acid remained difficult using the system reported 
previously. I 00, 101 In this paper, we generated smaller 
connector channels by deleting the internal loop segments of 
gpl0 subunits and demonstrated its capability to detect 
ssDNA and ssRNA. The translocation events produced a 
25 uniform current blockade of 16-21%, with a peak value of 
-19%. This blockade percentage is approximately half of the 
dsDNA blockade through the native channel, even though 
the cross-sectional area of the mutant channel is only 60% as a 12 subunit from when assembled into the functional 
viral capsid (Orlova et al, 2003). The diameter of SPPl 
connector channel as 13 subunit form in the constrict part is 30 
2.8 nm, which is smaller than phi29 connector channel 
which is 3.6 nm. Similar to phi29 connector channel, struc-
ture analysis of SPPl connector revealed that the central 
surface region of SPPl connector also shows slight hydro-
phobicity compared with the two flanking layers at both 
ends. 
of the wild type. 
Conclusion 
The deletion of an internal flexible segment from the gp 10 
subunit of the phi29 DNA packaging nanomotor resulted in 
a smaller conductance channel with a pore diameter -60% 
of the wild-type connector channel. While the single-
35 stranded nucleic acids could not be detected by wild type 
channel, they showed a blockade of 16-21% while translo-
cated through the smaller size channel. This mutant channel 
with smaller size is ideal for the detection and sensing of 
single-stranded nucleic acids, including ssDNA and ssRNA. 
Nanopore detection is an emerging technique that has 
been extensively used to study the DNA, RNA translocation 
given the promise of ultra-rapid nucleic acids sequencing. In 
contrast, study of polypeptide or protein translocation 
through a protein nanopore has not been pursued as aggres-
sively. One of the biggest challenges probably is due to the 
complexicity of protein or polypeptide which could fold into 
different structure and even interact with nanopore. Another 
problem is that neutral peptides cannot be driven through the 
nanopore under voltage. In addition, sequencing peptides or 
protein with nanopores is even more challenging since there 
are 20 common amino acids in nature protein compared to 
4 nucleotides in DNA. 
40 Connector channels created from gp 10 subunits with the 
internal loop deleted allowed for bidirectional translocation 
of single-stranded nucleic acids. This may also lead to the 
development of a hybrid system in which the smaller 
conductance channel can be reconstituted into a lipid 
45 bilayer, in conjunction with the wild type connector channel, 
for the simultaneous detection and sensing of both dsDNA 
and ssDNA. 
Materials and Methods 
Materials 
The insertions result in a uniform conductance distribu- 50 The phospholipids 1,2-diphytanoyl-sn-glycerol-3-phos-
tion, we first time Nanopores have been extensively utilized 
to study DNA, RNA and analytes. However, peptide or 
protein recognization or sequencing using nanopore tech-
nique is still not studies extensively and has been attract 
enough attention. Compared to the genome, the proteome is 
probably a much more accurate and direct indicator of the 
current health status of humans. Various modifications have 
been studied extensively on both biological nanopores and 
solid-state nanopores for use in nucleic acid sensing.110• 111 
The modification of biological nanopores can b e easily 
achieved by the insertion, deletion, or substitution of various 
amino acids.112, 113 Biological nanopores can also be 
modified by covalently linking molecular recognition agents 
in the interior lumen of the pores. 103 Solid-state nanopores, 
conversely, have been studied mainly by chemical modifi-
cations. Different assembly pathways from modified phage 
portal protein monomers have been reported on SPPl 94, 
phocholine (DPhPC) and 1,2-dioleoyl-sn-glycerol-3-phos-
phocholine (DOPC) were obtained from Avanti Polar Lip-
ids, Inc. Organic solvents (n-decane and chloroform) were 
purchased from Fisher Scientific, Inc. and TEDIA, Inc., 
55 respectively. The DNA and RNA oligonucleotides used in 
this study were obtained from Integrated DNA Technolo-
gies, Inc. All other reagents were purchased from Sigma-
Aldrich, Inc., if not specified. 
Cloning and Purification of the C-his SPPl Connector 
60 Protein 
Gene gp6 encoding SPPl connector on the C-terminus 
was syntheses by Genescript company and then cloned into 
PET3 vector between NhdeI and BamHI. A His-tag was 
inserted into the C-terminal for purification. Then the plas-
65 mid was transformed into BL 21 (DE3) for expression and 
purification. The transformed bacteria were cultured in 10 
ml Luria-Bertani medium overnight at 37° C. Then the 
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cultured bacteria were transferred to 1 L of fresh LB 
medium. 0.5 mM IPTG was added to the medium to induce 
protein expression when OD600 reached 0.5-0.6. The bacte-
ria were collected by centrifugation after 3 hours continue 
culture. Bacteria was lysed by passing through French press. 5 
Lysed cell was differentiated by centrifugation and super-
natant containing expressed protein was collected.=The 
supernatant was purified with Nickel affinity chromatogra-
phy (Novagen)120 . Cells were resuspended with His Binding 
Buffer (15% glycerol, 0.5 M NaCl, 5 mM Imidazole, 10 mM 10 
ATP, 50 mM Tris-Cl, pH 8.0), and the cleared lysate was 
loaded onto a His•Bind® Resin Colunm and washed with 
His Washing Buffer (15% glycerol, 0.5 M NaCl, 50 mM 
Imidazole, 10 mM ATP, 50 mM Tris-Cl, pH 8.0). The 
15 
His-tagged connector was eluted by His Elution Buffer (15% 
glycerol, 0.5 M NaCl, 0.5M Imidazole, 50 mM ATP, 50 mM 
Na2HPO4 -Tris-Cl, pH 8.0). 
28 
Purification of the DNA/RNA Used in the Experiment 
A synthetic 20-nt DNA fragment was purified by mixing 
a 100 µM stock of the oligonucleotide with an equal volume 
of 2xTBE buffer (178 mM Tris base, 178 mM boric acid, 2 
mM EDTA, pH 8.3). The oligonucleotide/TBE mixture was 
loaded onto an 8% (w/v) polyacrylamide gel containing 8 M 
urea-TBE. The DNA was electrophoresed through the gel at 
120 V for -1 h. After electrophoresis, the single-stranded 
DNA band was visualized as a shadow on a TLC plate with 
a hand-held UV light and then cut out of the gel. The gel 
containing the ssDNA was minced and the ssDNA was 
eluted from the gel fragments by incubating them in a small 
volume of elution buffer (0.5 M ammonium acetate) at 37° 
C. for 4 h. The gel fragments were pelleted by centrifugation 
and the supernatant was removed. The ssDNA was precipi-
tated from the supernatant by adding ½o volume of 3 M 
sodium acetate and 2.5 volumes of ethanol and storing the 
solution overnight at -20° C. The ssDNA was again pelleted Insertion of the Connector Protein into Preformed Lipid 
Bilayers 20 by centrifugation, and excess salt was removed by rinsing 
the ssDNA pellet with 70% ethanol. The purified ssDNA 
was dissolved and stored in TMS buffer (100 mM NaCl, 10 
mM MgC12 , 50 mM Tris-HCl, pH 8.0). A synthetic 20-nt 
Procedures have been recently developed00- 102• 104• 121 for 
the incorporation of connector channels into lipid bilayers. 
Planar bilayer lipid membranes (BLMs) were created in a 
BCH-lA horizontal BLM cell (Eastern Scientific, LLC). A 
Teflon® partition with a 0.2 mm aperture was placed in the 25 
apparatus to separate the top and bottom compartments of 
the BLM cell. A planar lipid bilayer of DPhPC was formed 
by painting the aperture with 0.5 µl of 3% (w/v) DPhPC in 
n-decane. A conducting buffer (1 M NaCl, 10 mM Tris-HCl, 
pH 7 .8) was added to both the top and bottom compartments 30 
of the BLM cell, and a Ag/ AgCl electrode was placed in the 
buffer of each compartment. The electrode in the bottom 
compartment was connected to the headstage of an Axo-
patch 200B amplifier (Axon Instruments, Inc.), and the 
electrode in the top compartment was grounded. 35 
ssRNA fragment was purified in a similar manner. 
Translocation Experiments of DNA and RNA 
Liposomes containing connector channels were added to 
the top compartment of the BLM cell. Soon after, highly 
conductive connector channel(s) were inserted into the pla-
nar BLM and a stepwise increase in current was observed. 
For translocation experiments, the purified ssDNA or 
ssRNA was mixed with conducting buffer and added to the 
top compartment in the BLM cell. The translocation of 
ssDNA or ssRNA was observed as transient blockades of the 
electrochemical current. 
The SPPl connector protein used in this example com-
prises the sequence of SEQ ID NO: 4. 
Example 4 
One-Way Traffic of SPPl Viral Motor Channel for 
Peptide Translocation 
A variety of bacterial viruses exist in diverse form in 
natural environment, however, many of them share lots of 
When a planar BLM was successfully formed in the 
aperture of the partition, separating the two compartments 
filled with buffer, the BLM acted as an insulator. Intact 
planar BLM exhibited no detectable electrical current 
between the two electrodes. GUVs (0.5-2.0 µl) containing 40 
connector channels were added to the top compartment. 
Membrane fusion between the liposomes and the BLM 
happened immediately after applying GUVs containing the 
connector protein, and it was found that a current passing 
through the connector channel could be recorded. 
Electrophysiological Measurements The headstage and 
Axopatch 200B patch clamp amplifier were connected to a 
DigiData 1440 analog-digital converter (Axon Instruments, 
Inc.) to monitor and record electrochemical currents through 
BLMs17• 18• 38 . The current recordings were low-pass filtered 50 
at a frequency of 1 kHz. The sampling frequency was 2 kHz 
45 similarities from shape, structure, and life cycle, to packag-
ing and infection mechanism. Recently, it was discovered a 
common mechanism of dsDNA translocation motors using 
one-way revolution mechanism, exits many bacteria and 
in all experiments, unless otherwise specified. The data were 
recorded and stored on a PC with pClamp 9.1 software 
(Axon Instruments, Inc.), and analyzed with the Clampfit 
module ofpClamp 9.1 and OriginPro 8.1 (OriginLab Cor- 55 
poration). 
Electrical potentials were applied across BLMs in experi-
ments with two different modes, holding potential mode and 
ramping potential mode with the pClamp 9.1 software. The 
ramping potential mode was used in the experiments to 60 
examine connector channel stability and DNA/RNA trans-
location orientation. In the holding potential mode, a con-
stant voltage ( either + 7 5 m V or - 75 m V) was applied across 
the BLM. In the ramping potential mode, a voltage which 
constantly increased over time, from either - 100 m V or 65 
+100 mV to -200 mV or +200 mV, was applied across the 
BLM. 
virus, including phi29, SPPl, T4, T7 and others. Among the 
complex system of many different phages, viral connector 
protein is one of the key components with turbine-like shape 
in phage genome packaging and ejection, shared by many 
bacteriophages and other viral system. Previously we have 
successfully inserted phi29 connector channel into lipid 
bilayer and found the one way traffic of DNA. Here we 
reported that inserted reengineered bacteriophage SPP 1 con-
nector channel also exercised a one-way traffic property for 
peptide translocation, as demonstrated by holding and ramp-
ing, voltage, electrode polarity switching, and quantification 
of peptide translocation frequency. These results indicate 
that most of the DNA packaging motors probably utilize the 
same one way traffic mechanism during DNA packing 
process. In addition, the observed single direction peptide 
transportation provide a novel system with a natural valve to 
control dsDNA loading and gene delivery in liposomes or 
peptide sequencing without using of gating control found in 
other biological channels. 
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Introduction. 
A variety of bacterial viruses exist in diverse form in 
natural environment, however, many of them share lots of 
similarities from shape, structure, and life cycle, to packag-
5 
ing and infection mechanism. Recently, it was discovered a 
common mechanism of dsDNA translocation motors using 
one-way revolution mechanism, exits many bacteria and 
virus, including phi29, SPPl, T4, T7 and others133-135 . An 
unusual feature of many linear dsDNA viruses is the pack- 10 
aging of their DNA into a preformed capsid, which is 
entropically unfavorable process and accomplished by an 
ATP-driven motor. The packaging motor of SPPl, composed 
gpl, gp2, and gp6, powers encapsulation of the 45.9 kb 
genome.128 The ingenious and dedicate design of viral DNA 15 
packaging motors and the novel mechanism of action has 
provoked a wide range of interest among scientists in many 
different areas. Various portal proteins share little homology 
in primary sequence, and varies in size129-131 , although, they 
exhibit considerable morphological similarity132. Portal pro- 20 
tein of SPPl and phi29 both have similar secondary struc-
ture and 3-D structure. Explicit engineering of the SPPl 
connector is possible because of its accessible crystal struc-
ture135-137. SPPl portal protein exists in 13-subunit form 
and the pseudoatomic structure with 12-subunits. The over- 25 
all diameter of 13-subunit form is -1.65 nm, and the height 
is -1.10 nm and the narrow part is 2.77 nm in 13 subunit 
form and 1.81 in 12 subunit form. 136• 137. 
30 
Results. 
Characterization ofReengineered SPPl Connector Chan-
nel 
As revealed in crystal structure, SPPl connector channel 
share similar structure with phi29 connector channel. To 
purify SPPl connector channel, 6xhis tag (SEQ ID NO: 11) 
was inserted downstream of a six-glycine linker (SEQ ID 
NO: 12) which was introduced to provide end flexibility. 
After purification to homogeneity, the molecular weight of 
single subunit of SPPl is 56 kDa, which is much higher than 
35 KDa of phi29 connector as revealed in SDS PAGE gel, 
in agreement with theoretical molecular weight. The purified 
reengineered SPPl connector channel was inserted into a 
planar lipid bilayer membrane (BLM) via two steps. First, 
the connector channel was incorporated into liposome and 
then connector complex was fused into lipid membrane. The 
discrete stepwise increase of the current was observed after 
the connectors inserted into the membrane. Each step size 
was about 200 pA under IM KCL 5 mM HEPES, pH 8 under 
50 m V, and the conductance is uniform and did not display 
voltage gating under the applied voltage. 
One-way traffic of peptide was probed by applying a 
constant holding voltage and by switching the voltage 
polarity to a membrane. There was no peptide translocation 
under either positive or negative voltage when no peptide is 
present in both chambers in a single channel study or 
multiple channel study. Peptide was pre-mixed in both 
chambers under a constant voltage. Under single channel, 
switching of voltage polarity showed that the connector 
In vitro, the biomimetic motor can be inserted into syn-
thetic nanodevices138· 139. In vivo, the artificial nanomotors 
can be also applied for loading drugs, delivering DNA/RNA, 
pumping ions, transporting cargoes, or driving the motion of 
components in the heart, eye or other sensing organs in the 
body. We have previously reengineered the connector pro-
tein and inserted the connector into lipid bilayers1920. The 
translocations of ions and peptide through the channel have 
been characterized to demonstrate the power of the SPPl 
connector for use in single DNA sensing and fingerprinting. 
30 channel allowed peptide a unidirectional translocation. 
Since the connector channel is incorporated into the lipid 
bilayer via the fusion of the liposome/connector complex, 
the direction of the connector cannot be controlled. The 
conformation of connector channel could be either C-termi-
35 nus facing the cis-chamber or N-terminus facing the cis-
chamber. 
In this study, we report that the reengineered SPPl motor 40 
channel exercises a one-way peptide traffic mechanism, 
which may related with the packaging mechanism. 
The correspondence to voltage switching was dependent 
upon the orientation of the connector in the BLM. For 
example, when there was no peptide translocation under 
positive potential, switching the voltage to negative poten-
tial resulted in peptide translocation. Similarly, translocation 
events appeared under positive voltage but disappeared 
when switch to negative voltage indicating the channel only 
allow one way traffic of peptide. Peptide translocation under Recently, chemically modified synthetic pores
141-144 and 
some reengineered protein channels145-147 have been found 
to have ion rectifying capabilities by allowing ions to flow 
in one direction. For example, a mutant 7R-a-haemolysin 
has been discovered to only allow ion transport under 
positive voltages even under high ion concentrations145 . 
Chemically modified synthetic pores can be made to exhibit 
electronic diode-like properties by a different mecha-
nism.14s. 149_ 
45 multiple channels was shown. Under positive voltage, the 
first inserted channel has not shown any translocation 
events, however, when the second channel inserted into 
membrane, a burst of translocation events appeared imme-
diately indicating the direction of two channel is opposite. 
50 Under positive voltage, the first channel has shown uniform 
blockade events. As expected, after switching the voltage to 
negative, there is no blockade events shown up, however, 
when the second channel inserted the blockade events 
Previously we have successfully inserted phi29 connector 
channel into lipid bilayer and found the one way traffic of 55 
DNA. Here we reported that inserted reengineered bacte-
riophage SPPl connector channel also exercised a one-way 
traffic property for peptide translocation, as demonstrated by 
holding and ramping, voltage, electrode polarity switching, 
and quantification of peptide translocation frequency. These 60 
results indicate that most of the DNA packaging motors 
probably utilizes the same one way traffic mechanism during 
DNA packing process. In addition, the observed single 
direction peptide transportation provide a novel system with 
a natural valve to control dsDNA loading and gene delivery 65 
in liposomes or peptide sequencing without using of gating 
control found in other biological channels. 
suddenly appeared in a uniform manner. To further verify 
the one-way traffic, peptide was added to one side of 
chamber after multiple channel insertion. If is found that the 
blockade events was only appeared in one side. When the 
peptide added to cis-chamber, the translocation events only 
appeared under negative voltage since the peptide is positive 
charged. Similar phenomenon was also observed when 
peptide was added to the trans-chamber. In addition, after 
added different ratio of peptide in the two chambers, the 
blockade events rate is also different corresponding to the 
ratio of peptide in both chambers. 
One-way traffic of peptide was probed by quantification 
of peptide translocation frequency in the presence of mul-
tiple channels. If connector channels allow peptide passing 
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changed after DNA packaging151 • 152 . Such significant rear-
rangements of the connector after DNA packaging, a similar 
feature reported in other phage systems as well136• 137• 153 
might change the channel configuration to reversely favor 
through only in one direction, the translocation frequency 
should be affected by a different conformation of connector 
orientation when multiple channels were inserted into the 
bilayer, regardless of the peptide concentration. Experiments 
were performed under a constant holding potential of -50 5 the DNA exit during infection. 
Materials and Methods 
Materials 
The phospholipid, 1,2-diphytanoyl-sn glycerol-3-phos-
phocholine (DPhPC) (Avanti Polar Lipids, Alabaster, Ala.), 
Nickel-NTA nanogold (1.8 nm; Nanoprobes), n-Decane 
(Fisher), chloroform (TEDIA) were used as instructed by the 
vendor. All other reagents were from Sigma, if not specified. 
The construction and purification of reengineered sppl 
C-terminal tagged connectors have been reported140• 154. 
Electrophysiological Measurements 
A bilayer was formed on a thin Teflon film partition 
(aperture 200 µm in diameter) which separates a BLM 
chamber into a cis- and trans-chamber (compartment). The 
cis-chamber refers to the grounded compartment to which 
the connector reconstituted liposome was added. Connector 
channel insertion into the bilayer has been described previ-
ously using vesicle fusion 19 . Briefly, connector reconstituted 
liposomes were prepared using a dehydration-rehydration 
method and further extruded to form unilamellar liposomes. 
m V and in the presence of varying concentrations of peptide. 
The current traces of multiple connector insertions revealed 
the change in the frequency of peptide translocation events. 
When one additional connector was incorporated with an 
opposite orientation that did not allow peptide to pass, the 10 
frequency of DNA translocation did not change. The inser-
tion of first channel allows the translocation of peptides from 
cis-chamber to trans-chamber under negative voltage. The 
additional insertion did not change the frequency due to the 
direction of second one is opposite to the first one which did 15 
not allow peptide translocation through that side. When one 
additional connector was incorporated with the same orien-
tation to the previous one, the frequency of DNA translo-
cation double depending if the direction allow peptide 
translocation. The second channel does not increase the 20 
translocation frequency because of the orientation is oppo-
site to the first one, which allow peptide translocation. When 
the third channel inserted, the translocation frequency 
doubled because the direction is the same as the first 
connector channel. 25 The reconstituted liposomes were further diluted by 10-fold 
using the conducting buffer before applying to BLM cham-
bers. The final concentration of added protein was 5-50 
µg/mL. 
One-way traffic of peptide was probed by applying a 
ramping potential to a membrane. Given that the connector 
channel is inserted into the BLM via the fusion of the 
liposome/connector complex with the BLM, the orientation 
of the connector channel is random. The application of a 
ramping potential to the BLM containing a single connector 
channel revealed a unidirectional translocation of peptide. A 
ramping voltage from -50 m V to +50 m V was applied to 
obtain the I-V curves. 
Discussion. 
Recently, Guo and Lee proposed a pushing or injection 
model 150 . In this model, the connector remains static; DNA 
translocation is induced by a DNA packaging enzyme or 
terminase, which pushes a certain length of DNA into the 
procapsid, and then shifts to bind to a far distal region of the 
DNA and inserts an additional section. This model does not 
exclude the socket wrench rotating motion by the enzyme. 
The studies reported here provide direct evidence to prove 
the model 150 . 
For electrophysiological measurements, both compart-
30 ments in the BLM chamber were filled with a conducting 
buffer (1 M NaCl/5 mM Tris, pH 7.8, ifnot specified). A pair 
of Ag/AgCl electrodes connected directly to both the com-
partments was used to measure the current traces across the 
bilayer lipid membrane. The current trace was recorded 
35 using anAxopatch 200B patch clamp amplifier coupled with 
the Axon DigiData 1322A analog-digital converter (Axon 
Instruments) or the BLM workstation (Warner Instruments). 
All voltages reported were those of the trans-compartment. 
Data was low band-pass filtered at a frequency of 5 kHz or 
40 1 KHz and acquired at a sampling frequency of 10 KHz. The 
PClamp 9.1 software (Axon Instruments) was used to collect 
the data, and the software Origin Pro 8.0 was used for data 
analysis. 
The SPPl connector protein used in this example com-
45 prises the sequence of SEQ ID NO: 4. It is very interesting to observe the counter-chirality 
between the left-handed sppl connector channel and the 
right-handed dsDNA. The sppl connector channel is com-
posed of 12 copies of the protein gpl0 with each existing as 
three-helices to encircle the channel, and exhibiting a left-
handed configuration. However, the regular viral dsDNA 50 
genome is the normal B-form DNA exhibiting a right-
handed configuration. As far as the energy is concerned, it is 
expected that such an opposite configuration would favor the 
ejection of the dsDNA during infection and would not favor 
the packaging during assembly. However, our findings 
revealed a contrasting phenomenon: under an external elec-
trical force, the channel favored DNA entry but blocked 
DNA exit, suggesting a very intriguing structure and motion 
mechanism for the motor. In this situation, the channel wall 
and the dsDNA constitute two counter-parallel helices. It is 
possible that the sequential attraction between the negative 
charge of the phosphate backbone and the positive charge of 
the channel wall, which contains two 12-lysine rings (aa 
#200, 209) separated by 2 nm (and possibly two more rings 
Example 5 
Three-Steps of Channel Conformational Twisting 
Related to Paused and Quantized Packaging During 
Directional Genome Translocation of Bacterial 
Virus SPPl 
The channel of the DNA-packaging motor of double-
55 stranded DNA virus allows viral genomic to enter the 
protein procapsid shell during viral maturation and to exit 
during host infection. We recently demonstrated that DNA 
packaging motor of bacterial virus phi29 exercises a one-
way traffic property, and uses a revolution mechanism 
60 without rotation for dsDNA packaging using a left-handed 
connector channel to gear the right-handed DNA. This raises 
a question of how dsDNA is ejected during infection using 
this one way valve. Previously, we reported the finding of 
three step gating in the channel of phi29 DNA packaging 
at locations K234, K235)129, will produce a step wise 
propelling force for DNA translocation. It has been reported 
that the conformation of the sppl connector is substantially 
65 motor, and proposed a conformational changes of motor 
channel during DNA packaging process to prepare for the 
reversal of dsDNA. To determine whether the finding and 
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proposed mechanism in phi29DNA packaging motor is 
universal, we cloned the gene gp-6 coding for SPPl con-
nector and, studied the conformational change of SPPl 
connector inserted into the lipid bilayer. We found reengi-
neered SPPl connector also exhibited conformational 
changes during DNA packaging process and three step 
gating. We investigated and linked the gating and confor-
mational change phenomenal to the quantized packaging 
studies of DNA in phi29 and T3 reported previously. It was 
found that the three step gating coincide with the three major 
steps of quantized DNA packaging intermediates. These 
finding lead to the conclusion that three step gating, is due 
to three step of motor conformational change that was 
revealed in three major step of quanlized packaging of DNA 
intermediate. This supports the speculation that the one way 
inbound channel were transformed into an outbound channel 
during the DNA packaging process and this finding will lead 
to the slight twisting of the dsDNA by a motor with 
revolution mechanism without rotation. 
1. Introduction 
Tailed bacterial viruses are widely distributed in nature 
and they shared many similarities, from structure, shape, to 
life cycle, packaging and infection mechanism. Among the 
complex system of many different phages, viral connector 
protein is one of the key components with turbine-like 
shape, shared by many bacteriophages and other viral sys-
tem. It was inserted into the prohead as major part of portal 
complex and responsible for genome packaging and ejec-
tion. Linear dsDNA viruses package their genome into a 
preformed protein shell referred as procapsid155 . This DNA 
encapsulation process is completed by a nanomotor using 
ATP as energy156- 160 . During this process, connector acts as 
34 
a valve mechanism for DNA packaging has also been 
observed.180 The reengineered connector channel is capable 
to discriminate single-strand DNA or RNA from double 
strand. By selectively engineering a probe on the connector, 
5 single chemicals and antibody can be identified based on 
their distinct fingerprints. 181 
Based on previous study, we further want to verify 
whether this phenomenon is universal. Here, we first time 
expressed reengineered SPPl connector and found this 
10 connector also exercises 3-step gating which is similar to 
phi29 connector. We also further investigate the effect of 
voltage polarity, pH, ion concentration, and type on the 
gating. This finding may indicate the phenomenon of con-
nector conformation change is common in most of the 
15 bacteriophages and share similar role in genome packaging 
and ejection. 
2. Materials and Methods 
2.1 Materials 
The phospholipid, 1,2-diphytanoyl-sn glycerol-3-phos-
20 phocholine (DPhPC) (Avanti Polar Lipids, Alabaster, Ala.), 
n-Decane (Fisher), chloroform (TEDIA) were used as 
instructed by the vendor. All other reagents were from 
Sigma, if not specified. 
2.2 Expression and Purification of Reengineered SPPl 
25 Connector 
Gene gp6 encoding SPPl connector on the C-terminus 
was syntheses by Genescript company and then cloned into 
PET3 vector between NhdeI and BamHI. A His-tag was 
inserted into the C-terminal for purification. Then the plas-
30 mid was transformed into BL 21 (DE3) for expression and 
purification. The transformed bacteria were cultured in 10 
ml Luria-Bertani medium overnight at 37° C. Then the 
cultured bacteria were transferred to 1 L of fresh LB 
medium. 0.5 mM IPTG was added to the medium to induce 
a docking point for ATPase which powers the DNA genome 
translocation. SPPl is a virulent dsDNA phage which infects 
Bacillus subtilis bacteriophages and the connector consists 35 
of portal protein gp6, and two head completion protein gp 15 
and gp 16.161 - 162 The molecular motor of SPPl, composed of 
gpl, gp2 and gp6, powers encapsulation of the 45.9 kbp 
genome. 163 The ingenious design of viral DNA packaging 
motors and the novel mechanism of action has irritated a 40 
protein expression when OD600 reached 0.5-0.6. The bac-
teria were collected by centrifugation after 3 hours continue 
culture. Bacteria was lysed by passing through French press. 
Cells were resuspended with His Binding Buffer (15% 
glycerol, 0.5 M NaCl, 5 mM Imidazole, 10 mMATP, 50 mM 
Tris-Cl, pH 8.0), and the cleared lysate was loaded onto a 
His•Bind® Resin Colunm and washed with His Washing wide range of interest among scientists in virology, molecu-
lar biology, structure biology, nanotechnology and other 
areas. Although various connectors share little homology in 
primary sequence and varies in size164- 166, they exhibit 
significant morphological similarity167 . Portal protein of 
SPPl and phi29 share similar secondary structure and 3-D 
structure. Our recent research also found that they even 
share similar role in packaging genome168- 1 70 . The structure 
of the SPPl connector has been previously solved by X-ray 
crystallography, 171 • 172 showing SPPl portal protein have 
13-subunit form and the pseudoatomic structure with 
12-subunits. The overall diameter of 13-subunit form is 
-1.65 nm, and the height is -1.10 nm. The narrow part is 
2.77 nm in 13 subunit form and 1.81 in 12 subunit form. 
Gating is very common in various ion channels or protein 
pores1 73 and plays a critical role in regulating ion transpor-
tation through a membrane and DNA translocation direction. 
By the nature of gating, ion channels could be classified174 
as ligand-gated175, stretch-gated176, voltage-gated177, or 
other gating174. Voltage-gated ion channels are sensitive to 
potential change near the channel, whereas the ligand-gated 
ion channels are activated by the binding of a chemical 
messenger (i.e., a ligand). 
Previous studies, the connector channel from bacterio-
phages phi29 has been inserted into lipid bilayers to serve as 
a membrane-embedded nanopore with robust properties. 1 78 • 
1 79 A one-way traffic property for dsDNA translocation with 
Buffer (15% glycerol, 0.5 M NaCl, 50 mM Imidazole, 10 
mMATP, 50 mM Tris-Cl, pH 8.0). The His-tagged connector 
was eluted by His Elution Buffer (15% glycerol, 0.5 M 
45 NaCl, 0.5M Imidazole, 50 mM ATP, 50 mM Tris-Cl, pH 
8.0). 
2.3 Electrophysiological Measurements 
A bilayer was formed on a thin Teflon film partition with 
aperture 200 µm in diameter. This partion separates the 
50 bilayer lipid membrane (BLM) chamber into two compart-
ments: a cis- and trans-chamber. The connector reconstituted 
liposome was added to the cis-chamber referred as grounded 
compartment. Phi29 connector channel insertion into the 
lipid bilayer has been reported previously using vesicle 
55 fusion178. Here we used the same procedure for reengi-
neered SPPl connector. Briefly, connector reconstituted 
liposomes were prepared using a dehydration-rehydration 
method and further extruded to form unilamellar liposomes. 
The reconstituted liposomes were further diluted by 10-fold 
60 using the conducting buffer before applying to BLM cham-
bers. For electrophysiological measurements, both compart-
ments of BLM chamber were filled with a conducting buffer. 
A pair of Ag/ AgCl electrodes inserted to both compartments 
was used to measure the current traces across the bilayer 
65 lipid membrane. The current trace was recorded using an 
Axopatch 200B patch clamp amplifier coupled with the 
BLM workstation (Warner Instruments). or the Axon Digi-
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Data 1322A analog-digital converter (Axon Instruments) All 
voltages reported were those of the trans-compartment from 
100 mv, 75 mV, 50 mV. Data was low band-pass filtered at 
36 
dependence and gating occurs much often under negative 
voltage than that under positive voltage. 
It was also observed that the gating of the connector 
channel was reversible. When a transmembrane voltage of0 a frequency of 5 kHz or 1 KHz and acquired at a sampling 
frequency of 10 KHz. The PC!amp 9.1 software (Axon 
Instruments) was used to collect the data, and the software 
Origin Pro 8.0 was used for data analysis. 
3. Results 
3.1 The Lipid Membrane-Embedded C-his SPPl Connec-
tor Display Uniform Conductance. 
5 pA applied for 10 to 30 seconds, the gated channel was 
observed to re-open. After the channel shutting down was 
triggered by higher voltage (-100 m V and -150 m V), a 
lower voltage was applied to allow the connector protein to 
recover. It was found that the conductance of the channels 
10 restored to their original state within 10 seconds. 
3 .3 pH Effect on Gating Property To facilitate connector purification, a C-terminal His tag 
was inserted downstream of the gp-6 gene. The reengineered 
connectors were purified to homogeneity and run on SDS-
PAGE gel with C-His phi29 connector as controls. The 
molecular weights of C-His tagged SPPl and phi29 con- 15 
nectar channel are 56 kDa and 35 kDa, respectively. After 
purification, the connector channels was first incorporated 
into liposome and then fused into lipid bilayer. The connec-
tor channel embedded into the lipid bilayer was stable and 
displayed a uniform conductance. The conductance ofreen- 20 
gineered SPPl connector channel is 2.06 nS under IM 
NaCL 5 mM HEPES pH 8.0. 
3.2 C-his SPPl Connector Exercise Discrete and Uniform 
Three Step Conformational Change 
At a low constant holding potential ( ±50 m V), the channel 25 
conductance is stable and there is no gating observed under 
both voltage in a long time recording. However, when a 
higher potential voltage is applied, a 3-step channel size 
reduction is often observed immediately thereafter, which is 
very similar to phi29 connector channel and other membrane 30 
gating behaviors. In the given experiment conduction (1 M 
KC! with 5 mM HEPES, pH 8), to induce gating, the positive 
voltage applied across the membrane need to be over 100 
mV. Under this voltage, single channel current jump is 
around 380 pA, and each reduction step size was 120 pA 35 
accounting for 32% of the entire channel. Whereas to induce 
gating under negative potential, the threshold value just need 
to be over 75 mV and each reduction step size was about 90 
pA still accounting for the 32% of the open channel. This 
3-step channel gating can be induced by the high voltage 40 
regardless the buffer conditions. It is also interesting to note 
that after the 3-step reduction, there was still a residual 
current of 20 pA opening, which is about -5.3% of one 
channel. Similar results were observed at phi29 connector 
channel. However, this closed channel can open immedi- 45 
ately if an opposite potential is applied or a lower voltage 
applied. 
3.3 Polarity Dependence Gating of C-his SPPl Gating 
When multiple channels inserted into lipid bilayer and 
reach a steady stage, the polarity was switched from positive 50 
potential to negative potential and it is interestingly found 
that the gating showed polarity dependence. A trace current 
of multiple channels at ±50, ±75 and ±100 mv. Under 50 
mV, IM NaCl, 5 mM Hepes pH 6, multiple channels have 
been continually incorporated into lipid bilayer until reach- 55 
ing a steady stage without any gating. When varies the 
voltage to +75 mV under the same buffer condition, there 
was still no gating observed for several minutes recording. 
However, when switching to - 75 m V, gating occurred 
immediately and continuously until the channels closing 60 
completely. Each reduction size is in agreement of the data 
in single channel study. When applied 100 m V voltage 
across the membrane under the same buffer condition, gating 
occurred immediately when switch to -100 m V. The gating 
step is still one third of one channel current jump which is 65 
the same as observed under single channel study. The data 
clearly shows that gating of C-his SPPl channel is polarity 
In order to further characterize the factors that affect the 
gating property of C-his SPPl channel, a series of pH has 
been tested. When pH increase to 10 and 12 under 1 M Na CL 
5 mM Hepes, 75 mV applied across the membrane, similar 
gating trend has been observed as it under pH 6 that gating 
occurred immediately when switching from positive voltage 
to negative voltage. When applied scanning voltage from 
-100 to 100 m V, similar phenomenon has been observed. 
However, the, the noise level change. 
When pH decrease from 6 to below 3, incorporation 
channels under 75 mV is very difficult. So to increase the 
incorporation chance, the voltage has been decreased to ±25 
m V. Under this voltage, it's interesting observing the voltage 
polarity dependence become opposite that the channel 
become very unstable under positive voltage but when 
switch to negative voltage, the channels became stable. This 
phenomenon has also been confirmed under scanning volt-
age. 
3.4 Salt Concentration Effect on Gating Property 
Salt concentration effect on the gating has also been 
investigated. In this study, we have investigated the gating 
property under 1 M, 0.5M, 0.2 M and 50 mM NaCl. As the 
concentration decrease to 0.5 M, the channels are stable 
under positive voltage but gating occurs immediately under 
-75 mV. However, when the concentration decreases to 
0.2M, the channels are stable under both positive and 
negative 7 5 m V voltage. Similar phenomenon has also been 
observed under 50 mM NaCl. 
4. Discussion 
Viral DNA packaging has been extensively studied in 
many viral systems, but the actual mechanism remains 
elusive. Many models have been proposed to interpret the 
mechanism of packaging process during the last several 
decades, including: 1) Ratchet mechanism182 2) Gyrase-
driven supercoiled and relaxation159• 183 • 184; 3) Brownian 
motion185 ; 4) Force of osmotic pressure186 5) Five-fold/six-
fold mismatch connector rotating thread187; 6) Supercoiled 
DNA wrapping188; 7) Electro-dipole within central chan-
nel 164; 8) Sequential action of motor components189• 190 and, 
9) Connector contraction hypothesis191 . All these models are 
intriguing, but none of them have been supported by con-
clusive experimental data; or in other cases, validated in one 
viral system but disproved in another. The five-fold/six-fold 
mismatch connector rotating thread model 187 has been 
popular for several decades, because this model could intro-
duce a new mechanical motor prototype. Numerous labora-
tories, including our own, have persevered to search, inter-
pret, even design a five-fold ring to fit findings to this 
fascinating model 190• 192- 194. Unfortunately, recent studies 
in many viral DNA packaging motors reveal that the stoi-
chiometry of motor components is an even number rather 
than an odd number195- 198 . In 1998, Guo and his colleagues 
first proposed a DNA packaging mechanism which is similar 
to the process of the translocation of dsDNA in hexameric 
AAA+ ATPase during DNA replication and repair. The 
finding of even-number subunits agree with the mechanism 
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of many other well-studied DNA tracking motors 199-202 and 
the AAA+ ATPase family. More recent 
publications194• 203 - 205 also support our findings 197• 198• 206 
that hexameric structure is built by pRNA dimer2°6 • X-ray 
crystallography study also confirmed that pRNA forms a 5 
dimer in solution which forms a tetramer without the pro-
capsid 194· 206 , supporting the theory that the dimer is the 
building unit of the hexamer and the sequential action in 
hexamer assembly is 2----;,4----;,6. It would be desirable if the 
mechanism of the sequential action among the channel 10 
subunits is elucidated in the future Recently, Guo and his 
colleagues discovered a third type of biomotor with revo-
lution mechanism without rotation in bacteriophages phi29. 
Later, they found this mechanism is very common in DNA 
translocation motors of viruses and bacteria, including 15 
HK97, SPPl, P22, T4, T7, cellular DNA translocase FtsK. 
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C-terminus. With this mutant, the discrete steps of 32% 
conductance change were not observed in the presence of 
streptavidin. However, conductance assay of the mutant 
connector by electrical ramping revealed that three-discrete 
steps of conformational changes were also observed. The 
finding suggests that conformational change was a result of 
the transition of the entire connector structure, and the 
C-terminal only served as a trigger. This conclusion agrees 
with the finding in the connector structure of bacteriophage 
P22 12. A unique topology of the C-terminal domain was 
reported to be a -200-A-long a-helical barrel that inserts 
deeply into the virion and is highly conserved in the 
Podoviridae family. They proposed that the barrel domain 
would facilitates genome spooling into the interior of the 
procapsid during DNA packaging, and in analogy to a rifle 
barrel to increases the accuracy of DNA ejection during 
infection. During the course of our investigation, we also 
found that the batch of the polyclonal antibody made a 
difference, suggesting that not all binding to any location of 
By employing revolution mechanism the motor can trans-
locate dsDAN free of coiling and torque which has solved 
many puzzles and debates occurred throughout the history of 
viral DNA packaging motor studies. 20 the C-terminus would induce conformational changes and 
certain epitope at the C-terminus was important for trigger-
ing the conformation change. 
Revolution involves the left-handed connector channel to 
facilitate the entry of the dsDNA during packaging1 70 • 180 . It 
would be reasonable to believe that, after DNA packaging is 
completed, a conformational changes will occur in order to 
convert the left-handed connector into the right-handed 25 
configuration to facilitate DNA exit to infect host cells. 
Indeed, three steps of conformational changes of phi29 
connector have been reported (Jia). In addition, previous 
studies have found that isolation of particles derived from 
DNA intermediates has shown three distinct peak, indicating 30 
that three step conformational change of connector may play 
an important role in the DNA packing process [Mary-Ann 
Bjornsti, 1983; Philip Serwer, 2014]. It is expected that a 
small right-handed twisting of the dsDNA will be observed 
since the dsDNA is aligned with the wall of the connector 35 
channel and the left- to right-handed conformational change. 
Biophysical studies to distinguish the very small angle 
right-handed twisting from the 3600/10.5 base pairs left-
handed rotation would be very interesting. 
The mechanism of ion channel gating has been exten-
sively studied174. The ligand-gated ion channels are regu-
lated by a ligand and are usually very selective to one or 
more ions such as Na+, K+, Ca2 +, or c1-. Such receptors 
located at synapses convert the chemical signal of a presyn-
aptically released neurotransmitter directly and very quickly 
into a postsynaptic electrical signal. Conformational 
changes of a helices in voltage-gated sodium channels and 
calcium channels have been proposed to explain the gating 
mechanism. From crystallographic structural studies of the 
SPPl connector protein, it is possible to surmise that when 
a potential difference is introduced over the membrane, the 
associated electromagnetic field induces a conformational 
change in the protein channel. From the structural viewpoint 
of a single chain in the connector protein, certain areas of the 
chain are flexible enough to induce a conformational change 
in response to an environmental stimuli. The interaction of 
dsDNA or SPPl terminal protein gp3 induces a conforma-
tional change that distorts the shape of the channel proteins 
sufficiently such that the cavity, or channel, opens to admit 
ion influx or efflux across the membrane, down its electro-
chemical gradient. This conformational change leads to the 
In addition, many studies have shown the expansion of 40 
procapsid during DNA packaging of bacteriophages.207-214· 
Connector is a crucial 1 component in the regulation of 
procapsid shape and size215 . Therefore, it is reasonable to 
assume that procapsid expansion is related to the connector 
conformational change. 
Our results support the proposal that these three steps of 
conformational change are responsible for packaging 
dsDNA and this is common in many viral DNA packaging 
motor. We demonstrated that the binding or contact of 
components to the C-terminal would result in the similar 50 
discrete steps of conformational change. Conductance assay 
using mutant connector conjugated with a Strep-tag to its 
C-terminal and inculcated with anti-strep tag antibody or 
nanogold coated with streptavidin revealed a three discrete 
steps of channel change with blockade of about 32%. It is 55 
reasonable to believe that the translocation of DNA into the 
procapsid or the internal pressure of the fully packaged 
DNA within the procapsid might lead to the contact of DNA 
with the C-terminal flexible domain, inducing a conforma-
tion changes with two subsequent functions: 1) to prevent 60 
the dsDNA from exit; and 2) to prepare a new channel 
configuration to facilitate the injection of DNA during the 
host cell infection process. The proposed second step of 
action has also been evidence in the P22 system213 . To 
further support this, a connector mutant with the removal of 
45 opening or closing of the channel, which will help to control 
the packaging or release of the viral genome. 
a 25 amino acid segment at each C-terminus of the 12 
subunits were constructed with a strep-tag conjugated to the 
The controllable opening and closing of the connector 
protein has been achieved with different polarity, which also 
resembles the voltage-gated ion channels. However, they 
have different functions in the biological environment. The 
ion channels may have to open and close multiple times in 
their life cycle, whereas the SPPl DNA connector protein 
might require less. The significantly different gating behav-
ior of the internal flexible loop-cleaved connector suggests 
that the flexible loops may play a key role in the voltage 
gating. Results described above show that after the removal 
of these loops, both the occurrence and extent of gating 
reduced tremendously. These loops can induce conforma-
tional changes to adjust the channel size in response to an 
applied potential. Further studies are necessary to investi-
gate if other domains of the connector protein also contrib-
ute to its gating and conformational changes. 
5. Conclusions 
Three step gating and a conformational changes of motor 
65 channel in the channel of SPPl connector has been found in 
this study, a phenomenal identical to the finding in phi29. We 
propose the gating and conformational change phenomenal 
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may link to the quantized packaging studies of DNA in 
phi29 and T3 reported previously. It was found that the three 
step gating coincide with the three major steps of quantized 
DNA packaging intermediates. These finding lead to the 
conclusion that three step gating, is due to three step of 5 
motor conformational change resulting in three major step of 
quanlized packaging or DNA intermediate, and support the 
speculation that the one way inbound channel were trans-
formed into an outbound channel during the DNA packaging 
process and this finding will lead to the slight twisting of the 10 
dsDNA by a motor with revolution mechanism without 
rotation. 
The SPPl connector protein used in this example com-
prises the sequence of SEQ ID NO: 4. 
All publications, patents, and patent applications men- 15 
tioned in this specification are herein incorporated by ref-
erence to the same extent as if each individual publication, 
patent, or patent application was specifically and individu-
ally indicated to be incorporated by reference, including the 
references set forth in the following list: 20 
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It will be understood that various details of the presently 
disclosed subject matter can be changed without departing 
from the scope of the subject matter disclosed herein. 
Furthermore, the foregoing description is for the purpose of 
illustration only, and not for the purpose of limitation. 
SEQUENCE LISTING 
Wild type SPPl connector channel, 
DNA sequence: 






































1. Mutant 1 with added Gly-Gly-His-His-His-His-His-His 
(SEQ ID NO, 14) on C-terminal (Gray labels indicate distinctions 
relative to wild type) 
DNA sequence: 
























SEQ ID NO, 4 
MADIYPLGKTHTEELNEIIVESAKEIAEPDTTMIQKLIDEHNPEPLLKGVRYYMCENDIEKKRRTYYD 
54 











2. Mutant 2 loop deletion. 
DNA sequence: 









































3. Mutant 3-grey labeled is position of mutation(s) 
E461G/E462G/E463G 
DNA sequence: 






































4. Mutant 4-grey labeled is position of mutation(s) D314N/D318N 






































<160> NUMBER OF SEQ ID NOS, 14 
<210> SEQ ID NO 1 
<211> LENGTH, 1512 
<212> TYPE, DNA 
<213> ORGANISM, Unknown 
<220> FEATURE, 
SEQUENCE LISTING 
<223> OTHER INFORMATION, Description of Unknown, 
Wild type SPPl connector channel sequence 
<400> SEQUENCE, 1 
atggctgata tctacccact agggaaaaca cacacagagg aactgaatga aatcatcgta 
gagagcgcga aggagatcgc agaaccggac acaaccatga tccagaagct tattgacgaa 
cataacccgg agccgctatt gaagggcgtc cggtactaca tgtgcgagaa cgacattgag 
aagaagcggc gcacatacta cgatgccgca ggacagcaat tagtggacga cacaaagacc 
aataaccgta ctagccacgc atggcacaag ctgtttgtgg atcagaaaac acagtaccta 
gtgggtgagc ctgttacatt cacatcagac aataagacgt tattagagta cgtcaatgag 
cttgcagacg acgactttga cgacattttg aacgagacag tcaagaatat gtcaaacaag 
ggtattgaat actggcatcc gttcgttgat gaagaagggg aatttgatta tgttattttc 
ccggctgagg aaatgattgt tgtatacaaa gacaacaccc gccgcgacat cctttttgcc 
ctccgctact actcatacaa gggcatcatg ggtgaagaga cacagaaagc agagctgtac 
acagacacac acgtttacta ctacgaaaaa attgacggcg tttatcagat ggactattca 
tatggcgaaa ataacccccg gccgcatatg acaaagggtg gacaagccat aggatgggga 
agagtaccga tcatcccgtt caaaaacaat gaggaaatgg tgtccgatct taaattctac 
aaggatttaa tcgacaatta cgacagcatc acatccagca caatggactc attcagcgac 
ttccaacaaa ttgtgtacgt gctcaaaaac tatgacgggg agaacccgaa agaattcacg 
gcgaatttaa ggtaccacag tgtaattaag gtatcgggcg atggtggtgt tgacacttta 
cgggctgaaa tacctgtgga tagtgccgca aaagagcttg aaagaataca agatgagctg 
tataaatccg ctcaggctgt ggataattca ccagaaacaa tcggaggagg ggctacaggc 
ccagcactgg aaaaccttta tgcgctactc gacttgaaag cgaacatggc tgaacggaaa 
atacgggctg gattgcgctt gttcttttgg ttcttcgctg aatacctacg caacacaggg 
aagggcgatt ttaacccgga taaagagctt acaatgacgt tcacacgcac taggattcag 
aatgacagcg agattgttca gagtcttgta caaggcgtta caggtggcat catgagtaaa 
gagacggccg tcgcacgcaa tccatttgtc caagacccag aggaagaatt ggcccgcata 
gaagaggaaa tgaaccaata cgctgaaatg cagggcaacc tactcgacga tgagggcggg 
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<210> SEQ ID NO 2 
<211> LENGTH, 503 
<212> TYPE, PRT 




<223> OTHER INFORMATION, Description of Unknown, 
Wild type SPPl connector channel sequence 
<400> SEQUENCE, 2 
Met Ala Asp Ile Tyr Pro Leu Gly Lys Thr His Thr Glu Glu Leu Asn 
1 5 10 15 
Glu Ile Ile Val Glu Ser Ala Lys Glu Ile Ala Glu Pro Asp Thr Thr 
20 25 30 
Met Ile Gln Lys Leu Ile Asp Glu His Asn Pro Glu Pro Leu Leu Lys 
35 40 45 
Gly Val Arg Tyr Tyr Met Cys Glu Asn Asp Ile Glu Lys Lys Arg Arg 
50 55 60 
Thr Tyr Tyr Asp Ala Ala Gly Gln Gln Leu Val Asp Asp Thr Lys Thr 
65 70 75 80 
Asn Asn Arg Thr Ser His Ala Trp His Lys Leu Phe Val Asp Gln Lys 
85 90 95 
Thr Gln Tyr Leu Val Gly Glu Pro Val Thr Phe Thr Ser Asp Asn Lys 
100 105 110 
Thr Leu Leu Glu Tyr Val Asn Glu Leu Ala Asp Asp Asp Phe Asp Asp 
115 120 125 
Ile Leu Asn Glu Thr Val Lys Asn Met Ser Asn Lys Gly Ile Glu Tyr 
130 135 140 
Trp His Pro Phe Val Asp Glu Glu Gly Glu Phe Asp Tyr Val Ile Phe 
145 150 155 160 
Pro Ala Glu Glu Met Ile Val Val Tyr Lys Asp Asn Thr Arg Arg Asp 
165 170 175 
Ile Leu Phe Ala Leu Arg Tyr Tyr Ser Tyr Lys Gly Ile Met Gly Glu 
180 185 190 
Glu Thr Gln Lys Ala Glu Leu Tyr Thr Asp Thr His Val Tyr Tyr Tyr 
195 200 205 
Glu Lys Ile Asp Gly Val Tyr Gln Met Asp Tyr Ser Tyr Gly Glu Asn 
210 215 220 
Asn Pro Arg Pro His Met Thr Lys Gly Gly Gln Ala Ile Gly Trp Gly 
225 230 235 240 
Arg Val Pro Ile Ile Pro Phe Lys Asn Asn Glu Glu Met Val Ser Asp 
245 250 255 
Leu Lys Phe Tyr Lys Asp Leu Ile Asp Asn Tyr Asp Ser Ile Thr Ser 
260 265 270 
Ser Thr Met Asp Ser Phe Ser Asp Phe Gln Gln Ile Val Tyr Val Leu 
275 280 285 
Lys Asn Tyr Asp Gly Glu Asn Pro Lys Glu Phe Thr Ala Asn Leu Arg 
290 295 300 
Tyr His Ser Val Ile Lys Val Ser Gly Asp Gly Gly Val Asp Thr Leu 
305 310 315 320 
Arg Ala Glu Ile Pro Val Asp Ser Ala Ala Lys Glu Leu Glu Arg Ile 
325 330 335 
Gln Asp Glu Leu Tyr Lys Ser Ala Gln Ala Val Asp Asn Ser Pro Glu 
340 345 350 
Thr Ile Gly Gly Gly Ala Thr Gly Pro Ala Leu Glu Asn Leu Tyr Ala 
355 360 365 
64 
US 10,648,966 B2 
65 
-continued 
Leu Leu Asp Leu Lys Ala Asn Met Ala Glu Arg Lys Ile Arg Ala Gly 
370 375 380 
Leu Arg Leu Phe Phe Trp Phe Phe Ala Glu Tyr Leu Arg Asn Thr Gly 
385 390 395 400 
Lys Gly Asp Phe Asn Pro Asp Lys Glu Leu Thr Met Thr Phe Thr Arg 
405 410 415 
Thr Arg Ile Gln Asn Asp Ser Glu Ile Val Gln Ser Leu Val Gln Gly 
420 425 430 
Val Thr Gly Gly Ile Met Ser Lys Glu Thr Ala Val Ala Arg Asn Pro 
435 440 445 
Phe Val Gln Asp Pro Glu Glu Glu Leu Ala Arg 
450 455 
Asn Gln Tyr Ala Glu Met Gln Gly Asn Leu 
465 470 
Asp Asp Asp Leu Glu Glu Asp Asp Pro 
485 
Gly Gly Ala Gly Gln Val Ser 
500 
<210> SEQ ID NO 3 
<211> LENGTH, 1536 
<212> TYPE, DNA 







Ile Glu Glu Glu Met 
460 
Asp Asp Glu Gly Gly 
480 
Gly Ala Ala Glu Ser 
495 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polynucleotide 
<400> SEQUENCE, 3 
atggctgata tctacccact agggaaaaca cacacagagg aactgaatga aatcatcgta 
gagagcgcga aggagatcgc agaaccggac acaaccatga tccagaagct tattgacgaa 
cataacccgg agccgctatt gaagggcgtc cggtactaca tgtgcgagaa cgacattgag 
aagaagcggc gcacatacta cgatgccgca ggacagcaat tagtggacga cacaaagacc 
aataaccgta ctagccacgc atggcacaag ctgtttgtgg atcagaaaac acagtaccta 
gtgggtgagc ctgttacatt cacatcagac aataagacgt tattagagta cgtcaatgag 
cttgcagacg acgactttga cgacattttg aacgagacag tcaagaatat gtcaaacaag 
ggtattgaat actggcatcc gttcgttgat gaagaagggg aatttgatta tgttattttc 
ccggctgagg aaatgattgt tgtatacaaa gacaacaccc gccgcgacat cctttttgcc 
ctccgctact actcatacaa gggcatcatg ggtgaagaga cacagaaagc agagctgtac 
acagacacac acgtttacta ctacgaaaaa attgacggcg tttatcagat ggactattcg 
tatggcgaaa ataacccccg gccgcacatg acaaagggtg gacaagccat aggatgggga 
agagtaccga tcatcccgtt caaaaacaat gaggaaatgg tgtccgatct taaattctac 
aaggatttaa tcgacaatta cgacagcatc acatccagca caatggactc attcagcgac 
ttccaacaaa ttgtgtacgt gctcaaaaac tatgacgggg agaacccgaa agaattcacg 
gcgaatttaa ggtaccacag tgtaattaag gtatcgggcg atggtggtgt tgacacttta 
cgggctgaaa tacctgtgga tagtgccgca aaagagcttg aaagaataca agatgagctg 
tataaatccg ctcaggctgt ggataattca ccagaaacaa tcggaggagg ggctacaggc 
ccagcactgg aaaaccttta tgcgctactc gacttgaaag cgaacatggc tgaacggaaa 
atacgggctg gattgcgctt gttcttttgg ttcttcgctg aatacctacg caacacaggg 
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aatgacagcg agattgttca gagtcttgta caaggcgtta caggtggcat catgagtaaa 
gagacggccg tcgcacgcaa tccatttgtc caagacccag aggaagaatt ggcccgcata 
gaagaggaaa tgaaccaata cgctgaaatg cagggcaacc tactcgacga tgagggcggg 
gatgatgatt tagaggagga tgatccaaat gccggagccg cagaatcagg aggagctgga 
caagtatctg gtggccacca tcaccatcac cattag 
<210> SEQ ID NO 4 
<211> LENGTH, 511 
<212> TYPE, PRT 







<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polypeptide 
<400> SEQUENCE, 4 
Met Ala Asp Ile Tyr Pro Leu Gly Lys Thr His Thr Glu Glu Leu Asn 
1 5 10 15 
Glu Ile Ile Val Glu Ser Ala Lys Glu Ile Ala Glu Pro Asp Thr Thr 
20 25 30 
Met Ile Gln Lys Leu Ile Asp Glu His Asn Pro Glu Pro Leu Leu Lys 
35 40 45 
Gly Val Arg Tyr Tyr Met Cys Glu Asn Asp Ile Glu Lys Lys Arg Arg 
50 55 60 
Thr Tyr Tyr Asp Ala Ala Gly Gln Gln Leu Val Asp Asp Thr Lys Thr 
65 70 75 80 
Asn Asn Arg Thr Ser His Ala Trp His Lys Leu Phe Val Asp Gln Lys 
85 90 95 
Thr Gln Tyr Leu Val Gly Glu Pro Val Thr Phe Thr Ser Asp Asn Lys 
100 105 110 
Thr Leu Leu Glu Tyr Val Asn Glu Leu Ala Asp Asp Asp Phe Asp Asp 
115 120 125 
Ile Leu Asn Glu Thr Val Lys Asn Met Ser Asn Lys Gly Ile Glu Tyr 
130 135 140 
Trp His Pro Phe Val Asp Glu Glu Gly Glu Phe Asp Tyr Val Ile Phe 
145 150 155 160 
Pro Ala Glu Glu Met Ile Val Val Tyr Lys Asp Asn Thr Arg Arg Asp 
165 170 175 
Ile Leu Phe Ala Leu Arg Tyr Tyr Ser Tyr Lys Gly Ile Met Gly Glu 
180 185 190 
Glu Thr Gln Lys Ala Glu Leu Tyr Thr Asp Thr His Val Tyr Tyr Tyr 
195 200 205 
Glu Lys Ile Asp Gly Val Tyr Gln Met Asp Tyr Ser Tyr Gly Glu Asn 
210 215 220 
Asn Pro Arg Pro His Met Thr Lys Gly Gly Gln Ala Ile Gly Trp Gly 
225 230 235 240 
Arg Val Pro Ile Ile Pro Phe Lys Asn Asn Glu Glu Met Val Ser Asp 
245 250 255 
Leu Lys Phe Tyr Lys Asp Leu Ile Asp Asn Tyr Asp Ser Ile Thr Ser 
260 265 270 
Ser Thr Met Asp Ser Phe Ser Asp Phe Gln Gln Ile Val Tyr Val Leu 
275 280 285 
Lys Asn Tyr Asp Gly Glu Asn Pro Lys Glu Phe Thr Ala Asn Leu Arg 
290 295 300 
68 
US 10,648,966 B2 
69 
-continued 
Tyr His Ser Val Ile Lys Val Ser Gly Asp Gly Gly Val Asp Thr Leu 
305 310 315 320 
Arg Ala Glu Ile Pro Val Asp Ser Ala Ala Lys Glu Leu Glu Arg Ile 
325 330 335 
Gln Asp Glu Leu Tyr Lys Ser Ala Gln Ala Val Asp Asn Ser Pro Glu 
340 345 350 
Thr Ile Gly Gly Gly Ala Thr Gly Pro Ala Leu Glu Asn Leu Tyr Ala 
355 360 365 
Leu Leu Asp Leu Lys Ala Asn Met Ala Glu Arg Lys Ile Arg Ala Gly 
370 375 380 
Leu Arg Leu Phe Phe Trp Phe Phe Ala Glu Tyr Leu Arg Asn Thr Gly 
385 390 395 400 
Lys Gly Asp Phe Asn Pro Asp Lys Glu Leu Thr Met Thr Phe Thr Arg 
405 410 415 
Thr Arg Ile Gln Asn Asp Ser Glu Ile Val Gln Ser Leu Val Gln Gly 
420 425 430 
Val Thr Gly Gly Ile Met Ser Lys Glu Thr Ala Val Ala Arg Asn Pro 
435 440 445 
Phe Val Gln Asp Pro Glu Glu Glu Leu Ala Arg Ile Glu Glu Glu Met 
450 455 460 
Asn Gln Tyr Ala Glu Met Gln Gly Asn Leu 
465 
Asp Asp Asp Leu Glu 
485 
Gly Gly Ala Gly Gln 
500 
<210> SEQ ID NO 5 
<211> LENGTH, 1491 
<212> TYPE, DNA 
470 
Glu Asp Asp Pro 
Val Ser Gly Gly 
505 





Leu Asp Asp Glu Gly 
475 
Ala Gly Ala Ala Glu 
495 





<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polynucleotide 
<400> SEQUENCE, 5 
atggctgata tctacccact agggaaaaca cacacagagg aactgaatga aatcatcgta 60 
gagagcgcga aggagatcgc agaaccggac acaaccatga tccagaagct tattgacgaa 120 
cataacccgg agccgctatt gaagggcgtc cggtactaca tgtgcgagaa cgacattgag 180 
aagaagcggc gcacatacta cgatgccgca ggacagcaat tagtggacga cacaaagacc 240 
aataaccgta ctagccacgc atggcacaag ctgtttgtgg atcagaaaac acagtaccta 300 
gtgggtgagc ctgttacatt cacatcagac aataagacgt tattagagta cgtcaatgag 360 
cttgcagacg acgactttga cgacattttg aacgagacag tcaagaatat gtcaaacaag 420 
ggtattgaat actggcatcc gttcgttgat gaagaagggg aatttgatta tgttattttc 480 
ccggctgagg aaatgattgt tgtatacaaa gacaacaccc gccgcgacat cctttttgcc 540 
ctccgctact actcatacaa gggcatcatg ggtgaagaga cacagaaagc agagctgtac 600 
acagacacac acgtttacta ctacgaaaaa attgacggcg tttatcagat ggactattcg 660 
tatggcgaaa ataacccccg gccgcacatg acaaagggtg gacaagccat aggatgggga 720 
agagtaccga tcatcccgtt caaaaacaat gaggaaatgg tgtccgatct taaattctac 780 
aaggatttaa tcgacaatta cgacagcatc acatccagca caatggactc attcagcgac 840 
ttccaacaaa ttgtgtacgt gctcaaaaac tatgacgggg agaacccgaa agaattcacg 900 
70 











<210> SEQ ID NO 6 
<211> LENGTH, 496 



































<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polypeptide 
<400> SEQUENCE, 6 
Met Ala Asp Ile Tyr Pro Leu Gly Lys Thr His Thr Glu Glu Leu Asn 
1 5 10 15 
Glu Ile Ile Val Glu Ser Ala Lys Glu Ile Ala Glu Pro Asp Thr Thr 
20 25 30 
Met Ile Gln Lys Leu Ile Asp Glu His Asn Pro Glu Pro Leu Leu Lys 
35 40 45 
Gly Val Arg Tyr Tyr Met Cys Glu Asn Asp Ile Glu Lys Lys Arg Arg 
50 55 60 
Thr Tyr Tyr Asp Ala Ala Gly Gln Gln Leu Val Asp Asp Thr Lys Thr 
65 70 75 80 
Asn Asn Arg Thr Ser His Ala Trp His Lys Leu Phe Val Asp Gln Lys 
85 90 95 
Thr Gln Tyr Leu Val Gly Glu Pro Val Thr Phe Thr Ser Asp Asn Lys 
100 105 110 
Thr Leu Leu Glu Tyr Val Asn Glu Leu Ala Asp Asp Asp Phe Asp Asp 
115 120 125 
Ile Leu Asn Glu Thr Val Lys Asn Met Ser Asn Lys Gly Ile Glu Tyr 
130 135 140 
Trp His Pro Phe Val Asp Glu Glu Gly Glu Phe Asp Tyr Val Ile Phe 
145 150 155 160 
Pro Ala Glu Glu Met Ile Val Val Tyr Lys Asp Asn Thr Arg Arg Asp 
165 170 175 
Ile Leu Phe Ala Leu Arg Tyr Tyr Ser Tyr Lys Gly Ile Met Gly Glu 
180 185 190 
Glu Thr Gln Lys Ala Glu Leu Tyr Thr Asp Thr His Val Tyr Tyr Tyr 
195 200 205 
Glu Lys Ile Asp Gly Val Tyr Gln Met Asp Tyr Ser Tyr Gly Glu Asn 
210 215 220 
Asn Pro Arg Pro His Met Thr Lys Gly Gly Gln Ala Ile Gly Trp Gly 
225 230 235 240 
Arg Val Pro Ile Ile Pro Phe Lys Asn Asn Glu Glu Met Val Ser Asp 
245 250 255 
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Leu Lys Phe Tyr Lys Asp Leu Ile Asp Asn Tyr Asp Ser Ile Thr Ser 
260 265 270 
Ser Thr Met Asp Ser Phe Ser Asp Phe Gln Gln Ile Val Tyr Val Leu 
275 280 285 
Lys Asn Tyr Asp Gly Glu Asn Pro Lys Glu Phe Thr Ala Asn Leu Arg 
290 295 300 
Tyr His Ser Val Ile Lys Val Ser Gly Asp Gly Gly Val Asp Thr Leu 
305 310 315 320 
Arg Ala Glu Ile Pro Val Asp Ser Ala Ala Lys Glu Leu Glu Arg Ile 
325 330 335 
Gln Asp Glu Leu Tyr Lys Ser Ala Gly Pro Ala Leu Glu Asn Leu Tyr 
340 345 350 
Ala Leu Leu Asp Leu Lys Ala Asn Met Ala Glu Arg Lys Ile Arg Ala 
355 360 365 
Gly Leu Arg Leu Phe Phe Trp Phe Phe Ala Glu Tyr Leu Arg Asn Thr 
370 375 380 
Gly Lys Gly Asp Phe Asn Pro Asp Lys Glu Leu Thr Met Thr Phe Thr 
385 390 395 400 
Arg Thr Arg Ile Gln Asn Asp Ser Glu Ile Val Gln Ser Leu Val Gln 
405 410 415 
Gly Val Thr Gly Gly Ile Met Ser Lys Glu Thr Ala Val Ala Arg Asn 
420 425 430 
Pro Phe Val Gln Asp Pro Glu Glu Glu Leu Ala Arg Ile Glu Glu Glu 
435 440 445 
Met Asn Gln Tyr Ala Glu Met Gln Gly Asn Leu Leu Asp Asp Glu Gly 
450 455 460 
Gly Asp Asp Asp Leu Glu Glu Asp Asp Pro Asn Ala Gly Ala Ala Glu 
465 470 475 480 
Ser Gly Gly Ala Gly Gln Val Ser Gly Gly His His His His His His 
485 490 495 
<210> SEQ ID NO 7 
<211> LENGTH, 1536 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polynucleotide 
<400> SEQUENCE, 7 
atggctgata tctacccact agggaaaaca cacacagagg aactgaatga aatcatcgta 60 
gagagcgcga aggagatcgc agaaccggac acaaccatga tccagaagct tattgacgaa 120 
cataacccgg agccgctatt gaagggcgtc cggtactaca tgtgcgagaa cgacattgag 180 
aagaagcggc gcacatacta cgatgccgca ggacagcaat tagtggacga cacaaagacc 240 
aataaccgta ctagccacgc atggcacaag ctgtttgtgg atcagaaaac acagtaccta 300 
gtgggtgagc ctgttacatt cacatcagac aataagacgt tattagagta cgtcaatgag 360 
cttgcagacg acgactttga cgacattttg aacgagacag tcaagaatat gtcaaacaag 420 
ggtattgaat actggcatcc gttcgttgat gaagaagggg aatttgatta tgttattttc 480 
ccggctgagg aaatgattgt tgtatacaaa gacaacaccc gccgcgacat cctttttgcc 540 
ctccgctact actcatacaa gggcatcatg ggtgaagaga cacagaaagc agagctgtac 600 
acagacacac acgtttacta ctacgaaaaa attgacggcg tttatcagat ggactattcg 660 
74 
















<210> SEQ ID NO 8 
<211> LENGTH, 511 

















































<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polypeptide 
<400> SEQUENCE, 8 
Met Ala Asp Ile Tyr Pro Leu Gly Lys Thr His Thr Glu Glu Leu Asn 
1 5 10 15 
Glu Ile Ile Val Glu Ser Ala Lys Glu Ile Ala Glu Pro Asp Thr Thr 
20 25 30 
Met Ile Gln Lys Leu Ile Asp Glu His Asn Pro Glu Pro Leu Leu Lys 
35 40 45 
Gly Val Arg Tyr Tyr Met Cys Glu Asn Asp Ile Glu Lys Lys Arg Arg 
50 55 60 
Thr Tyr Tyr Asp Ala Ala Gly Gln Gln Leu Val Asp Asp Thr Lys Thr 
65 70 75 80 
Asn Asn Arg Thr Ser His Ala Trp His Lys Leu Phe Val Asp Gln Lys 
85 90 95 
Thr Gln Tyr Leu Val Gly Glu Pro Val Thr Phe Thr Ser Asp Asn Lys 
100 105 110 
Thr Leu Leu Glu Tyr Val Asn Glu Leu Ala Asp Asp Asp Phe Asp Asp 
115 120 125 
Ile Leu Asn Glu Thr Val Lys Asn Met Ser Asn Lys Gly Ile Glu Tyr 
130 135 140 
Trp His Pro Phe Val Asp Glu Glu Gly Glu Phe Asp Tyr Val Ile Phe 
145 150 155 160 
Pro Ala Glu Glu Met Ile Val Val Tyr Lys Asp Asn Thr Arg Arg Asp 
165 170 175 
Ile Leu Phe Ala Leu Arg Tyr Tyr Ser Tyr Lys Gly Ile Met Gly Glu 
180 185 190 
Glu Thr Gln Lys Ala Glu Leu Tyr Thr Asp Thr His Val Tyr Tyr Tyr 
195 200 205 
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Glu Lys Ile Asp Gly Val Tyr Gln Met Asp Tyr Ser Tyr Gly Glu Asn 
210 215 220 
Asn Pro Arg Pro His Met Thr Lys Gly Gly Gln Ala Ile Gly Trp Gly 
225 230 235 240 
Arg Val Pro Ile Ile Pro Phe Lys Asn Asn Glu Glu Met Val Ser Asp 
245 250 255 
Leu Lys Phe Tyr Lys Asp Leu Ile Asp Asn Tyr Asp Ser Ile Thr Ser 
260 265 270 
Ser Thr Met Asp Ser Phe Ser Asp Phe Gln Gln Ile Val Tyr Val Leu 
275 280 285 
Lys Asn Tyr Asp Gly Glu Asn Pro Lys Glu Phe Thr Ala Asn Leu Arg 
290 295 300 
Tyr His Ser Val Ile Lys Val Ser Gly Asp Gly Gly Val Asp Thr Leu 
305 310 315 320 
Arg Ala Glu Ile Pro Val Asp Ser Ala Ala Lys Glu Leu Glu Arg Ile 
325 330 335 
Gln Asp Glu Leu Tyr Lys Ser Ala Gln Ala Val Asp Asn Ser Pro Glu 
340 345 350 
Thr Ile Gly Gly Gly Ala Thr Gly Pro Ala Leu Glu Asn Leu Tyr Ala 
355 360 365 
Leu Leu Asp Leu Lys Ala Asn Met Ala Glu Arg Lys Ile Arg Ala Gly 
370 375 380 
Leu Arg Leu Phe Phe Trp Phe Phe Ala Glu Tyr Leu Arg Asn Thr Gly 
385 390 395 400 
Lys Gly Asp Phe Asn Pro Asp Lys Glu Leu Thr Met Thr Phe Thr Arg 
405 410 415 
Thr Arg Ile Gln Asn Asp Ser Glu Ile Val Gln Ser Leu Val Gln Gly 
420 425 430 
Val Thr Gly Gly Ile Met Ser Lys Glu Thr Ala Val Ala Arg Asn Pro 
435 440 445 
Phe Val Gln Asp Pro Glu Glu Glu Leu Ala Arg Ile Gly Gly Gly Met 
450 455 460 
Asn Gln Tyr Ala Glu Met Gln Gly Asn Leu Leu Asp Asp Glu Gly Gly 
465 470 475 480 
Asp Asp Asp Leu Glu Glu Asp Asp Pro Asn Ala Gly Ala Ala Glu Ser 
485 490 495 
Gly Gly Ala Gly Gln Val Ser Gly Gly His His His His His His 
500 505 510 
<210> SEQ ID NO 9 
<211> LENGTH, 1536 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polynucleotide 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Combined DNA/RNA Molecule, 
Synthetic polynucleotide 
<400> SEQUENCE, 9 
atggctgata tctacccact agggaaaaca cacacagagg aactgaatga aatcatcgta 
gagagcgcga aggagatcgc agaaccggac acaaccatga tccagaagct tattgacgaa 
cataacccgg agccgctatt gaagggcgtc cggtactaca tgtgcgagaa cgacattgag 
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aataaccgta ctagccacgc atggcacaag ctgtttgtgg atcagaaaac acagtaccta 
gtgggtgagc ctgttacatt cacatcagac aataagacgt tattagagta cgtcaatgag 
cttgcagacg acgactttga cgacattttg aacgagacag tcaagaatat gtcaaacaag 
ggtattgaat actggcatcc gttcgttgat gaagaagggg aatttgatta tgttattttc 
ccggctgagg aaatgattgt tgtatacaaa gacaacaccc gccgcgacat cctttttgcc 
ctccgctact actcatacaa gggcatcatg ggtgaagaga cacagaaagc agagctgtac 
acagacacac acgtttacta ctacgaaaaa attgacggcg tttatcagat ggactattcg 
tatggcgaaa ataacccccg gccgcacatg acaaagggtg gacaagccat aggatgggga 
agagtaccga tcatcccgtt caaaaacaat gaggaaatgg tgtccgatct taaattctac 
aaggatttaa tcgacaatta cgacagcatc acatccagca caatggactc attcagcgac 
ttccaacaaa ttgtgtacgt gctcaaaaac tatgacgggg agaacccgaa agaattcacg 
gcgaatttaa ggtaccacag tgtaattaag gtatcgggca auggtggtgt taacacttta 
cgggctgaaa tacctgtgga tagtgccgca aaagagcttg aaagaataca agatgagctg 
tataaatccg ctcaggctgt ggataattca ccagaaacaa tcggaggagg ggctacaggc 
ccagcactgg aaaaccttta tgcgctactc gacttgaaag cgaacatggc tgaacggaaa 
atacgggctg gattgcgctt gttcttttgg ttcttcgctg aatacctacg caacacaggg 
aagggcgatt ttaacccgga taaagagctt acaatgacgt tcacacgcac taggattcag 
aatgacagcg agattgttca gagtcttgta caaggcgtta caggtggcat catgagtaaa 
gagacggccg tcgcacgcaa tccatttgtc caagacccag aggaagaatt ggcccgcata 
gaagaggaaa tgaaccaata cgctgaaatg cagggcaacc tactcgacga tgagggcggg 
gatgatgatt tagaggagga tgatccaaat gccggagccg cagaatcagg aggagctgga 
caagtatctg gtggccacca tcaccatcac cattag 
<210> SEQ ID NO 10 
<211> LENGTH, 511 
<212> TYPE, PRT 
























<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
polypeptide 
<400> SEQUENCE, 10 
Met Ala Asp Ile Tyr Pro Leu Gly Lys Thr His Thr Glu Glu Leu Asn 
1 5 10 15 
Glu Ile Ile Val Glu Ser Ala Lys Glu Ile Ala Glu Pro Asp Thr Thr 
20 25 30 
Met Ile Gln Lys Leu Ile Asp Glu His Asn Pro Glu Pro Leu Leu Lys 
35 40 45 
Gly Val Arg Tyr Tyr Met Cys Glu Asn Asp Ile Glu Lys Lys Arg Arg 
50 55 60 
Thr Tyr Tyr Asp Ala Ala Gly Gln Gln Leu Val Asp Asp Thr Lys Thr 
65 70 75 80 
Asn Asn Arg Thr Ser His Ala Trp His Lys Leu Phe Val Asp Gln Lys 
85 90 95 
Thr Gln Tyr Leu Val Gly Glu Pro Val Thr Phe Thr Ser Asp Asn Lys 
100 105 110 
Thr Leu Leu Glu Tyr Val Asn Glu Leu Ala Asp Asp Asp Phe Asp Asp 
115 120 125 
80 
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Ile Leu Asn Glu Thr Val Lys Asn Met Ser Asn Lys Gly Ile Glu Tyr 
130 135 140 
Trp His Pro Phe Val Asp Glu Glu Gly Glu Phe Asp Tyr Val Ile Phe 
145 150 155 160 
Pro Ala Glu Glu Met Ile Val Val Tyr Lys Asp Asn Thr Arg Arg Asp 
165 170 175 
Ile Leu Phe Ala Leu Arg Tyr Tyr Ser Tyr Lys Gly Ile Met Gly Glu 
180 185 190 
Glu Thr Gln Lys Ala Glu Leu Tyr Thr Asp Thr His Val Tyr Tyr Tyr 
195 200 205 
Glu Lys Ile Asp Gly Val Tyr Gln Met Asp Tyr Ser Tyr Gly Glu Asn 
210 215 220 
Asn Pro Arg Pro His Met Thr Lys Gly Gly Gln Ala Ile Gly Trp Gly 
225 230 235 240 
Arg Val Pro Ile Ile Pro Phe Lys Asn Asn Glu Glu Met Val Ser Asp 
245 250 255 
Leu Lys Phe Tyr Lys Asp Leu Ile Asp Asn Tyr Asp Ser Ile Thr Ser 
260 265 270 
Ser Thr Met Asp Ser Phe Ser Asp Phe Gln Gln Ile Val Tyr Val Leu 
275 280 285 
Lys Asn Tyr Asp Gly Glu Asn Pro Lys Glu Phe Thr Ala Asn Leu Arg 
290 295 300 
Tyr His Ser Val Ile Lys Val Ser Gly Asn Gly Gly Val Asn Thr Leu 
305 310 315 320 
Arg Ala Glu Ile Pro Val Asp Ser Ala Ala Lys Glu Leu Glu Arg Ile 
325 330 335 
Gln Asp Glu Leu Tyr Lys Ser Ala Gln Ala Val Asp Asn Ser Pro Glu 
340 345 350 
Thr Ile Gly Gly Gly Ala Thr Gly Pro Ala Leu Glu Asn Leu Tyr Ala 
355 360 365 
Leu Leu Asp Leu Lys Ala Asn Met Ala Glu Arg Lys Ile Arg Ala Gly 
370 375 380 
Leu Arg Leu Phe Phe Trp Phe Phe Ala Glu Tyr Leu Arg Asn Thr Gly 
385 390 395 400 
Lys Gly Asp Phe Asn Pro Asp Lys Glu Leu Thr Met Thr Phe Thr Arg 
405 410 415 
Thr Arg Ile Gln Asn Asp Ser Glu Ile Val Gln Ser Leu Val Gln Gly 
420 425 430 
Val Thr Gly Gly Ile Met Ser Lys Glu Thr Ala Val Ala Arg Asn Pro 
435 440 445 
Phe Val Gln Asp Pro Glu Glu Glu Leu Ala Arg Ile Glu Glu Glu Met 
450 455 460 
Asn Gln Tyr Ala Glu Met Gln Gly Asn Leu Leu Asp Asp Glu Gly Gly 
465 470 475 480 
Asp Asp Asp Leu Glu Glu Asp Asp Pro Asn Ala Gly Ala Ala Glu Ser 
485 490 495 
Gly Gly Ala Gly Gln Val Ser Gly Gly His His His His His His 
500 
<210> SEQ ID NO 11 
<211> LENGTH, 6 
<212> TYPE, PRT 
505 
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-continued 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
6xHis tag 
<400> SEQUENCE, 11 
His His His His His His 
1 5 
<210> SEQ ID NO 12 
<211> LENGTH, 6 
<212> TYPE, PRT 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
tag 
<400> SEQUENCE, 12 
Gly Gly Gly Gly Gly Gly 
1 5 
<210> SEQ ID NO 13 
<211> LENGTH, 12 
<212> TYPE, PRT 
<213> ORGANISM: Human immunodeficiency virus 
<400> SEQUENCE, 13 
Cys Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1 5 10 
<210> SEQ ID NO 14 
<211> LENGTH, 8 
<212> TYPE, PRT 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
tag 
<400> SEQUENCE, 14 
Gly Gly His His His His His His 
1 5 
What is claimed is: 
1. A nucleic acid molecule encoding a SPPl connector 
polypeptide variant, wherein the polypeptide comprises the 
amino acid sequence of SEQ ID NO:6, SEQ ID NO:8, or 45 
SEQ ID NO:10. 
2. The nucleic acid molecule of claim 1, having the 
sequence of SEQ ID NO:5, SEQ ID NO:7, or SEQ ID NO:9. 
3. A SPPl connector polypeptide variant, wherein the 
polypeptide comprises the amino acid sequence of SEQ ID 50 
NO:6, SEQ ID NO:8, or SEQ ID NO:10. 
4. A SPPl connector polypeptide variant, wherein the 
polypeptide comprises an amino acid sequence encoded by 
a polypeptide comprising an ammo acid sequence 
encoded by a nucleic acid molecule having the 
sequence of SEQ ID NO:5, SEQ ID NO:7, or SEQ 
ID NO:9. 
6. The conductive channel-containing membrane of claim 
5, wherein SPPl connector polypeptide variant comprises a 
detectable label. 
7. The conductive channel-containing membrane of claim 
6, wherein the detectable label is selected from the group 
consisting of a colorimetric indicator, a GCMS tag com-
pound, a fluorescent indicator, a luminescent indicator, a 
phosphorescent indicator, a radiometric indicator, a dye, an a nucleic acid molecule having the sequence of SEQ ID 
NO:5, SEQ ID NO:7, or SEQ ID NO:9. 
5. A conductive channel-containing membrane, compris-
ing: 
55 enzyme, a substrate of an enzyme, an energy transfer mol-
ecule, a quantum dot, a metal particle and an affinity label. 
(a) a membrane layer; and 
8. The conductive channel-containing membrane of claim 
5, wherein the membrane layer comprises a lipid layer. 
(b) a SPPl connector polypeptide variant that is incorpo-
rated into the membrane layer to form an aperture 
through which conductance can occur when an electri-
cal potential is applied across the membrane, wherein 
the SPPl connector polypeptide variant is selected 
from: 
9. The conductive channel-containing membrane of claim 
60 8, wherein the lipid layer comprises amphipathic lipids. 
a polypeptide comprising the amino acid sequence of 65 
SEQ ID NO:6, SEQ ID NO:8, or SEQ ID NO:10; 
and 
10. The conductive channel-containing membrane of 
claim 9, wherein the amphipathic lipids comprise phospho-
lipids and the lipid layer comprises a lipid bilayer. 
11. The conductive channel-containing membrane of 
claim 8, wherein the lipid layer is selected from the group 
consisting of a planar membrane layer and a liposome. 
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12. The conductive channel-containing membrane of 
claim 11, wherein the liposome is selected from the group 
consisting of a multilamellar liposome and a unilamellar 
liposome. 
13. The conductive channel-containing membrane of 5 
claim 5, wherein the incorporated SPPl connector polypep-
tide variant is mobile in the membrane layer. 
14. The conductive channel-containing membrane of 
claim 5, which is capable of translocating a single stranded 
nucleic acid molecule, a double-stranded nucleic acid mo!- 10 
ecule, and/or a polypeptide through the aperture when the 
electrical potential is applied, wherein said conductive chan-
nel-containing membrane is capable of polypeptide detec-
tion, identification, sequencing, and discrimination. 
* * * * * 
15 
86 
